Document:

Exhibit 10.8

                                     AMENDED
                          CERTIFICATE OF DESIGNATION OF
                            SERIES A PREFERRED STOCK

                                       OF

                         NEXHORIZON COMMUNICATIONS, INC.

It is hereby certified that:

         1. The name of the Company  (hereinafter called  the "Company") is Nex-
Horizon Communications, Inc., a Delaware corporation.

         2. The  Certificate  of  Incorporation  of the Company  authorizes  the
issuance of Five Million (5,000,000) shares of preferred stock, $.0001 par value
per share,  and  expressly  vests in the Board of  Directors  of the Company the
authority provided therein to issue any or all of said shares in one (1) or more
series and by resolution or resolutions to establish the  designation and number
and to fix the relative rights and preferences of each series to be issued.

         3. The Board of  Directors of the  Company,  pursuant to the  authority
expressly  vested in it as  aforesaid,  has  adopted the  following  resolutions
creating a Series A issue of Preferred Stock:

         RESOLVED,  that Four Million Two Hundred Fifty Thousand  (4,250,000) of
the Five Million  (5,000,000)  authorized  shares of  Preferred  Stock par value
$.0001 of the Company shall be designated  Series A Preferred Stock,  $.0001 par
value per share, and shall possess the rights and preferences set forth below:

         Section 1. Designation and Amount. The shares of such series shall have
$.0001  par value and shall be  designated  as  Series A  Preferred  Stock  (the
"Series A Preferred  Stock") and the number of shares  constituting the Series A
Preferred Stock shall be Four Million Two Hundred Fifty Thousand (4,250,000).

         Section 2. Rank.  Except for the  voting  rights  specifically  granted
herein which shall have  priority over all other  outstanding  securities of the
Company,  the Series A Preferred Stock shall rank: (i) senior to any other class
or series of  outstanding  Preferred  Shares or series of  capital  stock of the
Company; (ii) prior to all of the Company's Common Stock, no par value per share
("Common  Stock");  (iii)  prior to any class or series of capital  stock of the
Company hereafter created not specifically  ranking by its terms senior to or on
parity with any Series A Preferred Stock of whatever subdivision  (collectively,
with the Common Stock and the Existing  Preferred Stock,  "Junior  Securities");
and (iv) on parity  with any class or series  of  capital  stock of the  Company
hereafter created  specifically ranking by its terms on parity with the Series A
Preferred Stock ("Parity Securities") in each case as to distributions of assets
upon liquidation, dissolution or winding up of the Company, whether voluntary or
involuntary   (all  such   distributions   being  referred  to  collectively  as
"Distributions").

         Section 3. Dividends.  The  Series  A  Preferred  Stock  shall  bear no
dividend.

<PAGE>

         Section 4.        Liquidation Preference.

                  (a) In the event of any liquidation, dissolution or winding up
of the Company, either voluntary or involuntary, the Holders of shares of Series
A  Preferred  Stock  shall  be  entitled  to  receive,   immediately  after  any
distributions  to Senior  Securities  required by the Company's  Certificate  of
Incorporation or any certificate of designation,  and prior in preference to any
distribution to Junior  Securities but in parity with any distribution to Parity
Securities, an amount per share equal to $1.00 per share. If upon the occurrence
of such  event,  and after  payment  in full of the  preferential  amounts  with
respect  to  the  Senior  Securities,  the  assets  and  funds  available  to be
distributed  among the  Holders  of the  Series A  Preferred  Stock  and  Parity
Securities  shall be  insufficient  to permit the payment to such Holders of the
full preferential amounts due to the Holders of the Series A Preferred Stock and
the Parity  Securities,  respectively,  then the entire  assets and funds of the
Company  legally  available  for  distribution  shall be  distributed  among the
Holders of the Series A  Preferred  Stock and the Parity  Securities,  pro rata,
based on the respective  liquidation  amounts to which each such series of stock
is entitled by the Company's Certificate of Incorporation and any certificate(s)
of designation relating thereto.

                  (b)  Upon  the  completion  of the  distribution  required  by
subsection  4(a), if assets remain in the Company,  they shall be distributed to
holders of Junior  Securities in accordance  with the Company's  Certificate  of
Incorporation including any duly adopted certificate(s) of designation.

         Section 5. Conversion.  The record  Holders of  this Series A Preferred
Stock shall have conversion rights as follows (the "Conversion Rights"):

                  (a) Right to  Convert.  On and after  January  1,  2009,  each
record Holder of Series A Preferred Stock shall be entitled (at the times and in
the amounts set forth below) and subject to the  Company's  right of  redemption
set forth in Section  6(a),  at the office of the Company or any transfer  agent
for the  Series A  Preferred  Stock  (the  "Transfer  Agent"),  to  convert  (in
multiples of one (1) share of Preferred Stock) as follows:

         On and after  January 1, 2009,  the  Holders of the Series A  Preferred
         Stock  shall,  collectively  have the right to  convert  all or part of
         their  Series A Preferred  Shares into that  number of  authorized  but
         unissued common shares of the Company, as follows.

         Conversion to Common

         1. After June 1, 2009,  the holder of Series A Preferred  Share holders
         may  convert to common  shares at the  conversion  price of 100% of the
         average  closing  price for the  preceding 5 days  divided by $1.00 per
         share of  Series  A. In the event  the  average  closing  price for the
         preceding  5 days is less  than the  minimum  floor  price of $1.00 per
         share or exceeds a maximum  ceiling price of $5.00 per share,  then the
         conversion shall occur at the floor price, if less than the floor price
         or at the ceiling price if greater than the ceiling price.

                  (b)  Mechanics  of  Conversion.  In order to convert  Series A
Preferred  Stock into full shares of Common  Stock,  the Holder  shall (i) fax a
copy of the fully executed notice of conversion  ("Notice of Conversion") to the
Company  at the  office of the  Company or its  designated  transfer  agent (the
"Transfer  Agent")  for the Series A  Preferred  Stock  stating  that the Holder
elects to convert, which notice shall specify the date of conversion, the number

                                       2

<PAGE>

of shares of Series A Preferred Stock to be converted, the applicable conversion
price and a  calculation  of the number of shares of Common Stock  issuable upon
such conversion  (together with a copy of the front page of each  certificate to
be converted)  and (ii) surrender to a common courier for delivery to the office
of the Company or the Transfer Agent, the original certificates representing the
Series A Preferred Stock being converted (the "Preferred  Stock  Certificates"),
duly endorsed for  transfer;  provided,  however,  that the Company shall not be
obligated to issue  certificates  evidencing the shares of Common Stock issuable
upon  such  conversion  unless  either  the  Preferred  Stock  Certificates  are
delivered to the Company or its Transfer Agent as provided  above, or the Holder
notifies  the Company or its  Transfer  Agent that such  certificates  have been
lost,  stolen or destroyed  (subject to the  requirements  of  subparagraph  (i)
below).  Upon receipt by Company of a facsimile  copy of a Notice of Conversion,
Company shall immediately send, via facsimile,  a confirmation of receipt of the
Notice of Conversion to Holder which shall specify that the Notice of Conversion
has been received and the name and telephone  number of a contact  person at the
Company whom the Holder  should  contact  regarding  information  related to the
Conversion.  In the case of a dispute as to the  calculation  of the  Conversion
Rate,  the Company shall  promptly issue to the Holder the number of Shares that
are not  disputed  and shall  submit the  disputed  calculations  to its outside
accountant via facsimile  within three (3) days of receipt of Holder's Notice of
Conversion.  The Company shall cause the accountant to perform the  calculations
and notify  Company  and Holder of the  results no later than  forty-eight  (48)
hours  from  the  time  it  receives  the  disputed  calculations.  Accountant's
calculation shall be deemed conclusive absent manifest error.

                           (i)      Lost or Stolen Certificates. Upon receipt by
the Company of evidence of the loss,  theft,  destruction  or  mutilation of any
Preferred Stock  Certificates  representing  shares of Series A Preferred Stock,
and (in the case of  loss,  theft  or  destruction)  of  indemnity  or  security
reasonably  satisfactory to the Company,  and upon surrender and cancellation of
the Preferred Stock Certificate(s),  if mutilated, the Company shall execute and
deliver new  Preferred  Stock  Certificate(s)  of like tenor and date.  However,
Company shall not be obligated to re-issue such lost or stolen  Preferred  Stock
Certificates if Holder contemporaneously requests Company to convert such Series
A Preferred Stock into Common Stock.

                           (ii)     Delivery  of Common  Stock Upon  Conversion.
The Transfer Agent or the Company (as applicable) shall, no later than the close
of business on the third (3rd)  business day (the  "Deadline")  after receipt by
the Company or the Transfer  Agent of a facsimile copy of a Notice of Conversion
and receipt by Company or the Transfer Agent of all necessary documentation duly
executed and in proper form  required  for  conversion,  including  the original
Preferred Stock Certificates to be converted (or after provision for security or
indemnification  in the case of lost or destroyed  certificates,  if  required),
issue and surrender to a common courier for either  overnight or (if delivery is
outside the United  States) two (2) day delivery to the Holder at the address of
the Holder as shown on the stock  records of the Company a  certificate  for the
number of  shares of Common  Stock to which  the  Holder  shall be  entitled  as
aforesaid.

                           (iii)    No Fractional  Shares.  If any conversion of
the Series A Preferred Stock would create a fractional  share of Common Stock or
a right to acquire a fractional  share of Common Stock,  such  fractional  share
shall be  disregarded  and the number of shares of Common  Stock  issuable  upon
conversion, in the aggregate, shall be the next lower number of shares.

                                       3

<PAGE>

                  (c) Reservation of Stock Issuable Upon Conversion. The Company
shall at all times  reserve and keep  available  or make  provision to increase,
reserve and keep available out of its  authorized but unissued  shares of Common
Stock,  solely  for the  purpose of  effecting  the  conversion  of the Series A
Preferred Stock, such number of its shares of Common Stock as shall from time to
time be sufficient to effect the  conversion  of all then  outstanding  Series A
Preferred Stock; and if at any time the number of authorized but unissued shares
of Common Stock shall not be  sufficient  to effect the  conversion  of all then
outstanding  shares of Series A  Preferred  Stock,  the  Company  will take such
corporate  action as may be necessary to increase  its  authorized  but unissued
shares of Common Stock to such number of shares as shall be sufficient  for such
purpose.

                  (d)      Adjustment to Conversion Rate.

                           (i)      Adjustment to Fixed  Conversion Price Due to
Stock Split,  Stock  Dividend,  Etc. If, prior to the  conversion  of all of the
Series A Preferred  Stock,  the number of outstanding  shares of Common Stock is
increased  by a stock  split,  stock  dividend,  or  other  similar  event,  the
Conversion  Price  shall  be  proportionately  reduced,  or  if  the  number  of
outstanding   shares  of  Common  Stock  is  decreased  by  a   combination   or
reclassification  of shares,  or other similar event, the Conversion Price shall
be proportionately increased.

                           (ii)     Adjustment  Due  to  Merger,  Consolidation,
Etc. If, prior to the conversion of all Series A Preferred Stock, there shall be
any merger, consolidation, exchange of shares, recapitalization, reorganization,
or other  similar  event,  as a result of which  shares  of Common  Stock of the
Company  shall be changed  into the same or a different  number of shares of the
same or  another  class or  classes  of stock or  securities  of the  Company or
another  entity  or there is a sale of all or  substantially  all the  Company's
assets,  then the Holders of Series A Preferred Stock shall  thereafter have the
right to receive upon conversion of Series A Preferred Stock, upon the basis and
upon the terms and  conditions  specified  herein  and in lieu of the  shares of
Common Stock  immediately  theretofore  issuable  upon  conversion,  such stock,
securities  and/or other  assets  which the Holder  would have been  entitled to
receive in such  transaction  had the Series A  Preferred  Stock been  converted
immediately  prior  to  such  transaction,  and in  any  such  case  appropriate
provisions shall be made with respect to the rights and interests of the Holders
of the  Series  A  Preferred  Stock  to  the  end  that  the  provisions  hereof
(including, without limitation,  provisions for the adjustment of the Conversion
Price and of the  number of shares  issuable  upon  conversion  of the  Series A
Preferred Stock) shall thereafter be applicable, as nearly as may be practicable
in relation to any securities thereafter deliverable upon the exercise hereof.

                           (iii)    No  Fractional  Shares.  If  any  adjustment
under this Section  5(f) would  create a  fractional  share of Common Stock or a
right to acquire a fractional share of Common Stock, such fractional share shall
be disregarded and the number of shares of Common Stock issuable upon conversion
shall be the next lower number of shares.

         Section 6. Redemption by Company.  None.  The company has no redemption
right.

         Section 7. Voting Rights.  The Record Holders of the Series A Preferred
Shares  shall have the right to vote on any matter with  holders of common stock
voting together as one (1) class.  The Record Holders of the 4,250,000  Series A
Preferred  Shares  shall have that  number of votes  (identical  in every  other
respect to the voting rights of the holders of common stock  entitled to vote at
any  Regular or Special  Meeting of the  Shareholders)  equal to that  number of

                                       4

<PAGE>

common  shares on a one (1) to one (1) basis which  Delaware law provides may or
must be  approved  by vote or  consent  of the  holder of  common  shares or the
holders of other securities entitled to vote, if any.

         The Record  Holders of the Series A Preferred  Shares shall be entitled
to the same notice of any Regular or Special Meeting of the  Shareholders as may
or shall be given to holders of common shares entitled to vote at such meetings.

         For purposes of determining a quorum for any Regular or Special Meeting
of the  Shareholders,  the 4,250,000 Series A Preferred Shares shall be included
and shall be deemed as the equivalent of 4,250,000 of common shares  represented
at and  entitled  to vote  at such  meetings  or  less if some of the  Series  A
Preferred Shares have already been converted to common shares.

         Section 8.  Status of  Converted  or Redeemed  Stock.  In the event any
shares of Series A Preferred  Stock shall be converted  or redeemed  pursuant to
Section 5 or Section 6 hereof,  the shares so  converted  or  redeemed  shall be
canceled,  shall return to the status of authorized but unissued Preferred Stock
of no  designated  series,  and shall not be issuable by the Company as Series A
Preferred Stock.

         Section  9.  Preference  Rights.  Nothing  contained  herein  shall  be
construed  to prevent the Board of Directors of the Company from issuing one (1)
or more series of Preferred Stock with dividend and/or  liquidation  preferences
junior to the dividend  and  liquidation  preferences  of the Series A Preferred
Stock.

Signed on _________________

                                       5

<PAGE>

                                 SIGNATURE PAGE
            [Certificate of Designation of Series A Preferred Stock]

                                      By:_____________________________________
                                           President & Chief Executive Officer

STATE OF _________________ )
                           ) SS.
COUNTY OF _______________  )

     I, a Notary Public,  hereby certify that on the ____ day of ______________,
2008, _____________________________, personally appeared before me, who being by
me first duly sworn declared that he is the person who signed the foregoing, and
that the statements therein contained are true.

         IN WITNESS  WHEREOF,  I have  hereunto set my hand and seal on the date
hereinbefore mentioned.

My commission expires _______________________.

                                                   ----------------------------
                                                            Notary Public

                                       6Exhibit 10.12 

SECURITIES PURCHASE
AGREEMENT 

        SECURITIES
PURCHASE AGREEMENT (the “Agreement”), dated as of February 20,
2008, by and among Amish Naturals, Inc., a Nevada corporation, with headquarters located
at 8224 County Road 245, Holmesville, Ohio 44633 (the “Company”),
and the investors listed on the Schedule of Buyers attached hereto (individually, a
“Buyer” and collectively, the “Buyers”). 

      WHEREAS:

    A.                     The
Company and each Buyer is executing and delivering this Agreement in           reliance
upon the exemption from securities registration afforded by Section           4(2) of the
Securities Act of 1933, as amended (the “1933           Act”), and Rule
506 of Regulation D           (“Regulation D”) as promulgated by
the United States           Securities and Exchange Commission (the “SEC”)
under the 1933           Act.  

    B.                     The
Company has authorized a new series of senior secured convertible notes of           the
Company which notes shall be convertible into the Company’s common           stock,
par value $0.001 per share (the “Common Stock”), in
          accordance with the terms of the Notes (as defined below).  

    C.                     Each
Buyer wishes to purchase, and the Company wishes to sell, upon the terms           and
conditions stated in this Agreement, (i) that aggregate principal amount of           the
Notes, in substantially the form attached hereto as Exhibit A (the           “Notes”),
set forth opposite such Buyer’s name in column           (3) on the Schedule of
Buyers attached hereto (which aggregate amount for all           Buyers shall be
$3,125,000) (as converted, collectively, the “Conversion           Shares”),
(ii) warrants, in substantially the form attached hereto as Exhibit B-1 (the “Series
E Warrants”), to acquire that           number of shares of Common Stock set
forth opposite such Buyer’s name in           column (4) on the Schedule of Buyers
(as exercised, collectively, the           “Series EWarrant Shares”)
and (iii) warrants, in           substantially the form attached hereto as Exhibit B-2 (the
          “Series F Warrants”, and together with the Series E Warrants,
          the “Warrants”), to acquire that number of shares of Common
          Stock set forth opposite such Buyer’s name in column (5) on the Schedule
of           Buyers (as exercised, collectively, the “Series FWarrant
          Shares”, and together with the Series E Warrant Shares, the
          “Warrant Shares”).  

    D.                     The
Notes bear interest, which at the option of the Company, subject to certain
          conditions, may be paid in shares of Common Stock (the “Interest
          Shares”).  

    E.                     Concurrently
with the Closing (as defined below), the parties hereto are           executing and
delivering a Registration Rights Agreement, substantially in the           form attached
hereto as Exhibit C (the “Registration Rights           Agreement”),
pursuant to which the Company has agreed to provide           certain registration rights
with respect to the Registrable Securities (as           defined in the Registration
Rights Agreement) under the 1933 Act and the rules           and regulations promulgated
thereunder, and applicable state securities laws.  

    F.                     The
Notes, the Conversion Shares, the Interest Shares, the Warrants and the           Warrant
Shares collectively are referred to herein as the           “Securities”.  

    G.                     The
Notes will rank senior to all outstanding and future indebtedness of the
          Company, other than Permitted Senior Indebtedness (as defined in the Notes),
and           will be secured by a perfected security interest in all of the assets of
the           Company and the stock, equity interests and assets of each of the Company’s
          subsidiaries, as evidenced by (i) a pledge agreement, in the form attached
          hereto as Exhibit D (as amended or modified from time to time in
          accordance with its terms, the “Pledge Agreement”), (ii) a
          security agreement, in the form attached hereto as Exhibit E (as amended
          or modified from time to time in accordance with its terms, the           “Security
Agreement”), and (iii) the guaranties of the           subsidiaries of the
Company in the form attached hereto as Exhibit F (as           amended or modified
from time to time in accordance with its terms, the           “Guaranty” and,
together with the Pledge Agreement, the           Security Agreement and any ancillary
documents related thereto, collectively the “Security Documents”).  

        NOW,
THEREFORE, the Company and each Buyer hereby agree as follows: 

    1.           PURCHASE
AND SALE OF NOTES AND WARRANTS.  

    

          (a)           Purchase
of Notes and Warrants. Subject to the satisfaction (or waiver) of the
conditions set forth in Sections 6 and 7 below, the Company shall issue and sell
to each Buyer, and each Buyer severally, but not jointly, agrees to purchase
from the Company on the Closing Date (as defined below), (x) a principal amount
of Notes as is set forth opposite such Buyer’s name in column (3) on the
Schedule of Buyers, (y) Series E Warrants to acquire that number of Series E
Warrant Shares as is set forth opposite such Buyer’s name in column (4) on
the Schedule of Buyers (z) Series F Warrants to acquire that number of Series F
Warrant Shares as is set forth opposite such Buyer’s name in column (5) on
the Schedule of Buyers (the “Closing”). 

    

          (b)           Closing.
The date and time of the Closing (the “Closing Date”) shall be
10:00 a.m., New York City time, on the date hereof (or such later date as is
mutually agreed to by the Company and each Buyer) after notification of
satisfaction (or waiver) of the conditions to the Closing set forth in Sections
6 and 7 below at the offices of Schulte Roth & Zabel LLP, 919 Third Avenue,
New York, New York 10022. 

    
          (c)           Prepaid
Interest; Purchase Price.  

    
          
          (i)           Prepaid
Interest. The Company shall prepay the interest payable under the Notes
through the second anniversary of the Closing Date in such amount set forth opposite
such Buyer’s name in column (6) of the Schedule of Buyers (for each such
Buyer, its “Prepaid Interest”) which Prepaid Interest shall be
nonrefundable. 

    
          
          (ii)           Purchase
Price. The aggregate purchase price for the Notes and the           Warrants to be
purchased by each such Buyer at the Closing (the           “Purchase Price”)
shall be the amount set forth opposite each           Buyer’s name in column (7) of
the Schedule of Buyers. Each Buyer shall pay           $1,000 for each $1,000 of
principal amount of Notes and related Warrants to be           purchased by such Buyer at
the Closing.  

2 

    
          (d)           Form
of Payment. On the Closing Date, (i) each Buyer shall pay its           Purchase
Price less its Prepaid Interest (such net amount as set forth opposite           such
Buyer’s name in column (8) of the Schedule of Buyers, its “Net
          Purchase Price”) to the Company for the Notes and the Warrants to be
          issued and sold to such Buyer at the Closing, by wire transfer of immediately
          available funds in accordance with the Company’s written wire instructions
          and (ii) the Company shall deliver to each Buyer the Notes (allocated in
          the principal amounts as such Buyer shall request) which such Buyer is then
          purchasing hereunder along with the Warrants (allocated in the amounts as such
          Buyer shall request) which such Buyer is purchasing, in each case duly executed
          on behalf of the Company and registered in the name of such Buyer or its
          designee.  

    
          (e)           Consent.
Castlerigg Master Investments Ltd.           (“Castlerigg”), as the
majority holder of the September Notes           (as defined in the Notes), hereby
consents to the transactions contemplated           hereby, including, without
limitation, the issuance of the Notes and Warrants           and agrees that (x) the
Notes shall constitute Permitted Indebtedness (as           defined in the Existing
Notes) under the Existing Notes and the definition of           ” Permitted
Indebtedness” in the Existing Notes is hereby deemed to be           amended to
include all indebtedness under the Notes and (y) any liens with           respect to the
Security Documents shall constitute Permitted Liens (as defined           in the Existing
Notes) under the Existing Notes and the definition of           “Permitted Liens” in
the Existing Notes is hereby deemed to be amended           to include all liens granted
to the holders of the Notes pursuant to the           Security Documents.  

    
          (f)           September
Antidilution Adjustments. The Company and Castlerigg hereby           agree that for
purposes of clarification, the provisions set forth in Section           7(a) of the
September Notes and Section 2(a) of each of the warrants to purchase           Common
Stock issued pursuant to the September Securities Purchase Agreement (as
          defined in the Notes), the consideration received by the Company for each share
          of Common Stock issuable upon conversion of the Notes or exercise of any of the
          Warrants shall equal the quotient of (i) the sum of (x) the aggregate number of
          Conversion Shares issuable upon conversion of the Notes and (y) the aggregate
          number of Warrant Shares issuable upon exercise of the Warrants, divided by
(ii)           the sum of (x) the Purchase Price and (y) the aggregate exercise price of
the           Warrants, and no further adjustment will be due upon conversion of the
Notes or           exercise of the Warrants in accordance with the terms thereof on the
Closing           Date.  

    2.           BUYER’S
REPRESENTATIONS AND WARRANTIES. Each Buyer, severally and           not jointly,
represents and warrants with respect to only itself that:  

    
          (a)           No
Public Sale or Distribution. Such Buyer is (i) acquiring the Notes and           the
Warrants and (ii) upon conversion of the Notes and exercise of the Warrants
          (other than pursuant to a Cashless Exercise (as defined in the Warrants)) will
          acquire the Conversion Shares issuable upon conversion of the Notes and the
          Warrant Shares issuable upon exercise of the Warrants, for its own account and
          not with a view towards, or for resale in connection with, the public sale or
          distribution thereof, except pursuant to sales registered or exempted under the
          1933 Act; provided, however, that by making the representations
          herein, such Buyer does not agree to hold any of the Securities for any minimum
          or other specific term and reserves the right to dispose of the Securities at
          any time in accordance with or pursuant to a registration statement or an
          exemption under the 1933 Act. Such Buyer is acquiring the Securities hereunder
          in the ordinary course of its business. Such Buyer does not presently have any
          agreement or understanding, directly or indirectly, with any Person to
          distribute any of the Securities.  

3 

    
          (b)           Accredited
Investor Status. Such Buyer is an “accredited           investor” as that
term is defined in Rule 501(a) of Regulation D.  

    
          (c)           Reliance
on Exemptions. Such Buyer understands that the Securities are           being offered
and sold to it in reliance on specific exemptions from the           registration
requirements of United States federal and state securities laws and           that the
Company is relying in part upon the truth and accuracy of, and such           Buyer’s
compliance with, the representations, warranties, agreements,           acknowledgments
and understandings of such Buyer set forth herein in order to           determine the
availability of such exemptions and the eligibility of such Buyer           to acquire
the Securities.  

    
          (d)           Information.
Such Buyer and its advisors, if any, have been furnished           with all materials
relating to the business, finances and operations of the           Company and materials
relating to the offer and sale of the Securities which           have been requested by
such Buyer. Such Buyer and its advisors, if any, have           been afforded the
opportunity to ask questions of the Company. Neither such           inquiries nor any
other due diligence investigations conducted by such Buyer or           its advisors, if
any, or its representatives shall modify, amend or affect such           Buyer’s
right to rely on the Company’s representations and warranties           contained
herein. Such Buyer understands that its investment in the Securities           involves a
high degree of risk. Such Buyer has sought such accounting, legal and           tax
advice as it has considered necessary to make an informed investment           decision
with respect to its acquisition of the Securities.  

    
          (e)           No
Governmental Review. Such Buyer understands that no United States           federal
or state agency or any other government or governmental agency has           passed on or
made any recommendation or endorsement of the Securities or the           fairness or
suitability of the investment in the Securities nor have such           authorities
passed upon or endorsed the merits of the offering of the           Securities.  

    
          (f)           Transfer
or Resale. Such Buyer understands that except as provided in the
          Registration Rights Agreement: (i) the Securities have not been and are not
          being registered under the 1933 Act or any state securities laws, and may not
be           offered for sale, sold, assigned or transferred unless (A) subsequently
          registered thereunder, (B) such Buyer shall have delivered to the Company an
          opinion of counsel, in a generally acceptable form, to the effect that such
          Securities to be sold, assigned or transferred may be sold, assigned or
          transferred pursuant to an exemption from such registration, or (C) such Buyer
          provides the Company with reasonable assurance that such Securities can be
sold,           assigned or transferred pursuant to Rule 144 or Rule 144A promulgated
under the           1933 Act, as amended, (or a successor rule thereto) (collectively,
“Rule           144”); (ii) any sale of the Securities made in reliance
on Rule 144 may           be made only in accordance with the terms of Rule 144 and
further, if Rule 144           is not applicable, any resale of the Securities under
circumstances in which the           seller (or the Person (as defined in Section 3(s))
through whom the sale is           made) may be deemed to be an underwriter (as that term
is defined in the 1933           Act) may require compliance with some other exemption
under the 1933 Act or the           rules and regulations of the SEC thereunder; and
(iii) neither the Company nor           any other Person is under any obligation to
register the Securities under the           1933 Act or any state securities laws or to
comply with the terms and conditions           of any exemption thereunder. The
Securities may be pledged in connection with a           bona fide margin account or
other loan or financing arrangement secured by the           Securities and such pledge
of Securities shall not be deemed to be a transfer,           sale or assignment of the
Securities hereunder, and no Buyer effecting a pledge           of Securities shall be
required to provide the Company with any notice thereof           or otherwise make any
delivery to the Company pursuant to this Agreement or any           other Transaction
Document (as defined in Section 3(b)), including, without           limitation, this
Section 2(f).  

4 

    
          (g)           Legends.
Such Buyer understands that the certificates or other           instruments representing
the Notes and the Warrants and, until such time as the           resale of the Conversion
Shares and the Warrant Shares have been registered           under the 1933 Act as
contemplated by the Registration Rights Agreement, the           stock certificates
representing the Conversion Shares and the Warrant Shares,           except as set forth
below, shall bear any legend as required by the “blue           sky” laws of
any state and a restrictive legend in substantially the           following form (and a
stop-transfer order may be placed against transfer of such           stock certificates):  

	 	
[NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES
INTO WHICH THESE SECURITIES ARE [CONVERTIBLE] [EXERCISABLE]
HAVE BEEN][THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN] REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE
SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE
OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF
1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL, IN A GENERALLY ACCEPTABLE FORM, THAT
REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR
RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN
CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED
BY THE SECURITIES. 

The legend set forth above shall be
removed and the Company shall issue a certificate without such legend to the holder of the
Securities upon which it is stamped or issue to such holder by electronic delivery at the
applicable balance account at DTC (as defined below), unless otherwise required by state
securities laws, (i) such Securities are registered for resale under the 1933 Act, (ii) in
connection with a sale, assignment or other transfer, such holder provides the Company
with an opinion of counsel, in a generally acceptable form, to the effect that such sale,
assignment or transfer of the Securities may be made without registration under the
applicable requirements of the 1933 Act, or (iii) such holder provides the Company with
reasonable assurance that the Securities can be sold, assigned or transferred pursuant to
Rule 144 or Rule 144A. 

    
          (h)           Validity;
Enforcement. This Agreement, the Registration Rights Agreement           and the
Security Documents to which such Buyer is a party have been duly and           validly
authorized, executed and delivered on behalf of such Buyer and shall           constitute
the legal, valid and binding obligations of such Buyer enforceable           against such
Buyer in accordance with their respective terms, except as such           enforceability
may be limited by general principles of equity or to applicable           bankruptcy,
insolvency, reorganization, moratorium, liquidation and other           similar laws
relating to, or affecting generally, the enforcement of applicable           creditors’ rights
and remedies.  

5 

    
          (i)           No
Conflicts. The execution, delivery and performance by such Buyer of           this
Agreement, the Registration Rights Agreement and the Security Documents to
          which such Buyer is a party and the consummation by such Buyer of the
          transactions contemplated hereby and thereby will not (i) result in a violation
          of the organizational documents of such Buyer or (ii) conflict with, or
          constitute a default (or an event which with notice or lapse of time or both
          would become a default) under, or give to others any rights of termination,
          amendment, acceleration or cancellation of, any agreement, indenture or
          instrument to which such Buyer is a party, or (iii) result in a violation of
any           law, rule, regulation, order, judgment or decree (including federal and
state           securities laws) applicable to such Buyer, except in the case of clauses
(ii)           and (iii) above, for such conflicts, defaults, rights or violations which
would           not, individually or in the aggregate, reasonably be expected to have a
material           adverse effect on the ability of such Buyer to perform its obligations
          hereunder.  

    
          (j)           Residency.
Such Buyer is a resident of that jurisdiction specified below           its address on
the Schedule of Buyers.  

    3.           REPRESENTATIONS
AND WARRANTIES OF THE COMPANY.  

        
      The
Company represents and warrants to each of the Buyers that: 

    
          (a)           Organization
and Qualification. Each of the Company and its           “Subsidiaries” (which
for purposes of this Agreement means any           entity in which the Company, directly
or indirectly, owns any of the capital           stock or holds an equity or similar
interest) are entities duly organized and           validly existing in good standing
under the laws of the jurisdiction in which           they are formed, and have the
requisite power and authorization to own their           properties and to carry on their
business as now being conducted. Each of the           Company and its Subsidiaries is
duly qualified as a foreign entity to do           business and is in good standing in
every jurisdiction in which its ownership of           property or the nature of the
business conducted by it makes such qualification           necessary, except to the
extent that the failure to be so qualified or be in           good standing would not
have a Material Adverse Effect. As used in this           Agreement, “Material
Adverse Effect” means any material adverse           effect on the business,
properties, assets, operations, results of operations,           condition (financial or
otherwise) or prospects of the Company and its           Subsidiaries, taken as a whole,
or on the transactions contemplated hereby and           the other Transaction Documents
or by the agreements and instruments to be           entered into in connection herewith
or therewith, or on the authority or ability           of the Company to perform its
obligations under the Transaction Documents (as           defined below). The Company has
no Subsidiaries except as set forth on Schedule 3(a).  

6 

    
          (b)           Authorization;
Enforcement; Validity. The Company has the requisite power           and authority to
enter into and perform its obligations under this Agreement,           the Notes, the
Registration Rights Agreement, the Security Documents, each of           the Lock-Up
Agreements (as defined below), the Irrevocable Transfer Agent           Instructions (as
defined in Section 5(b)), the Warrants, and each of the other           agreements
entered into by the parties hereto in connection with the           transactions
contemplated by this Agreement (collectively, the           “Transaction Documents”)
and to issue the Securities in           accordance with the terms hereof and thereof.
The execution and delivery of the           Transaction Documents by the Company and the
consummation by the Company of the           transactions contemplated hereby and
thereby, including, without limitation, the           issuance of the Notes and the
Warrants, the reservation for issuance and the           issuance of the Conversion Sharesissuable
upon conversion of the Notes,           the reservation for issuance and issuance of
Warrant Shares issuable upon           exercise of the Warrants, the reservation for
issuance and issuance of Interest           Shares, if any, and the granting of a
security interest in the Collateral (as           defined in the Security Documents) have
been duly authorized by the           Company’s Board of Directors and (other than
(i) the filing of appropriate           UCC financing statements with the appropriate
states and other authorities           pursuant to the Security Agreement, and (ii) the
filing with the SEC of one or           more Registration Statements in accordance with
the requirements of the           Registration Rights Agreement) no further filing,
consent, or authorization is           required by the Company, its Board of Directors or
its stockholders. This           Agreement and the other Transaction Documents of even
date herewith have been           duly executed and delivered by the Company, and
constitute the legal, valid and           binding obligations of the Company, enforceable
against the Company in           accordance with their respective terms, except as such
enforceability may be           limited by general principles of equity or applicable
bankruptcy, insolvency,           reorganization, moratorium, liquidation or similar laws
relating to, or           affecting generally, the enforcement of applicable creditors’ rights
and           remedies.  

    
          (c)           Issuance
of Securities. The issuance of the Notes and the Warrants are           duly
authorized and are free from all taxes, liens and charges with respect to           the
issue thereof. As of the Closing, a number of shares of Common Stock shall           have
been duly authorized and reserved for issuance which equals or exceeds 130%           of
the aggregate of the maximum number of shares of Common Stock (i) issuable           upon
conversion of the Notes, (ii) as Interest Shares pursuant to the terms of           the
Notes and (iii) upon exercise of the Warrants (without taking into account           any
limitations on the Conversion of the Notes or exercise of the Warrants set
          forth in the Notes and Warrants, respectively). Upon conversion or payment in
          accordance with the Notes or exercise in accordance with the Warrants, as the
          case may be, the Conversion Shares, the Interest Shares and the Warrant Shares,
          respectively, will be validly issued, fully paid and nonassessable and free
from           all preemptive or similar rights, taxes, liens and charges with respect to
the           issue thereof, with the holders being entitled to all rights accorded to a
          holder of Common Stock. The offer and issuance by the Company of the Securities
          is exempt from registration under the 1933 Act.  

    
          (d)           No
Conflicts. The execution, delivery and performance of the Transaction
          Documents by the Company and the consummation by the Company of the
transactions           contemplated hereby and thereby (including, without limitation,
the issuance of           the Notes and the Warrants, the granting of a security interest
in the           Collateral and reservation for issuance and issuance of the Conversion
Shares,           the Interest Shares and the Warrant Shares) will not (i) result in a
violation           of any certificate of incorporation, certificate of formation, any
certificate           of designations or other constituent documents of the Company or
any of its           Subsidiaries, any capital stock of the Company or any of its
Subsidiaries or the           bylaws of the Company or any of its Subsidiaries or (ii)
conflict with, or           constitute a default (or an event which with notice or lapse
of time or both           would become a default) in any respect under, or give to others
any rights of           termination, amendment, acceleration or cancellation of, any
agreement,           indenture or instrument to which the Company or any of its
Subsidiaries is a           party, or (iii) result in a violation of any law, rule,
regulation, order,           judgment or decree (including foreign, federal and state
securities laws and           regulations and the rules and regulations The OTC Bulletin
Board (the           “Principal Market”)) applicable to the Company or
any of its           Subsidiaries or by which any property or asset of the Company or any
of its           Subsidiaries is bound or affected.  

7 

    
          (e)           Consents.
Neither the Company nor any of its Subsidiaries is required to           obtain any
consent, authorization or order of, or make any filing or           registration with,
any court, governmental agency or any regulatory or           self-regulatory agency or
any other Person in order for it to execute, deliver           or perform any of its
obligations under or contemplated by the Transaction           Documents, in each case in
accordance with the terms hereof or thereof. All           consents, authorizations,
orders, filings and registrations which the Company is           required to obtain
pursuant to the preceding sentence have been obtained or           effected on or prior
to the Closing Date, and the Company and its Subsidiaries           are unaware of any
facts or circumstances which might prevent the Company from           obtaining or
effecting any of the registration, application or filings pursuant           to the
preceding sentence. The Company is not in violation of the listing           requirements
of the Principal Market and has no knowledge of any facts which           would
reasonably lead to delisting or suspension of the Common Stock in the
          foreseeable future.  

    
          (f)           Acknowledgment
Regarding Buyer’s Purchase of Securities. The Company           acknowledges and
agrees that each Buyer is acting solely in the capacity of           arm’s length
purchaser with respect to the Transaction Documents and the           transactions
contemplated hereby and thereby and that no Buyer is (i) an officer           or director
of the Company, (ii) an “affiliate” of the Company or any           of its
Subsidiaries (as defined in Rule 144) or (iii) to the knowledge of the           Company,
a “beneficial owner” of more than 10% of the shares of Common           Stock
(as defined for purposes of Rule 13d-3 of the Securities Exchange Act of           1934,
as amended (the “1934 Act”)). The Company further           acknowledges
that no Buyer is acting as a financial advisor or fiduciary of the           Company or
any of its Subsidiaries (or in any similar capacity) with respect to           the
Transaction Documents and the transactions contemplated hereby and thereby,           and
any advice given by a Buyer or any of its representatives or agents in
          connection with the Transaction Documents and the transactions contemplated
          hereby and thereby is merely incidental to such Buyer’s purchase of the
          Securities. The Company further represents to each Buyer that the Company’s
          decision to enter into the Transaction Documents has been based solely on the
          independent evaluation by the Company and its representatives.  

    
          (g)           No
General Solicitation; Placement Agent’s Fees. Neither the           Company, nor
any of its Subsidiaries or affiliates, nor any Person acting on its           or their
behalf, has engaged in any form of general solicitation or general           advertising
(within the meaning of Regulation D) in connection with the offer or           sale of
the Securities. The Company shall be responsible for the payment of any
          placement agent’s fees, financial advisory fees, or brokers’          commissions
(other than for persons engaged by any Buyer or its investment           advisor)
relating to or arising out of the transactions contemplated hereby. The           Company
shall pay, and hold each Buyer harmless against, any liability, loss or           expense
(including, without limitation, attorney’s fees and out-of-pocket
          expenses) arising in connection with any such claim. The Company acknowledges
          that it has engaged Wharton Capital as placement agent (the “Placement
          Agent”) in connection with the sale of the Securities. Other than the
          Placement Agent, the Company has not engaged any placement agent or other agent
          in connection with the sale of the Securities.  

8 

    
          (h)           No
Integrated Offering. None of the Company, its Subsidiaries, any of           their
affiliates, and any Person acting on their behalf has, directly or           indirectly,
made any offers or sales of any security or solicited any offers to           buy any
security, under circumstances that would require registration of any of           the
Securities under the 1933 Act or cause this offering of the Securities to be
          integrated with prior offerings by the Company for purposes of the 1933 Act or
          any applicable stockholder approval provisions, including, without limitation,
          under the rules and regulations of any exchange or automated quotation system
on           which any of the securities of the Company are listed or designated. None of
the           Company, its Subsidiaries, their affiliates and any Person acting on their
          behalf will take any action or steps referred to in the preceding sentence that
          would require registration of any of the Securities under the 1933 Act or cause
          the offering of the Securities to be integrated with other offerings.  

    
          (i)           Dilutive
Effect. The Company understands and acknowledges that the number           of
Conversion Shares issuable upon conversion of the Notes and the Warrant           Shares
issuable upon exercise of the Warrants will increase in certain           circumstances.
The Company further acknowledges that its obligation to issue           Conversion Shares
upon conversion of the Notes in accordance with this Agreement           and the Notes
and its obligation to issue the Warrant Shares upon exercise of           the Warrants in
accordance with this Agreement and the Warrants is, in each           case, is absolute
and unconditional regardless of the dilutive effect that such           issuance may have
on the ownership interests of other stockholders of the           Company.  

    
          (j)           Application
of Takeover Protections; Rights Agreement. The Company and           its board of
directors have taken all necessary action, if any, in order to           render
inapplicable any control share acquisition, business combination, poison           pill
(including any distribution under a rights agreement) or other similar
          anti-takeover provision under the Articles of Incorporation or the laws of the
          jurisdiction of its formation which is or could become applicable to any Buyer
          as a result of the transactions contemplated by this Agreement, including,
          without limitation, the Company’s issuance of the Securities and any
          Buyer’s ownership of the Securities. The Company has not adopted a
          stockholder rights plan or similar arrangement relating to accumulations of
          beneficial ownership of Common Stock or a change in control of the Company. 

    
          (k)           SEC
Documents; Financial Statements. Except as disclosed in Schedule           3(k),
during the two (2) years prior to the date hereof, the Company has           filed all
reports, schedules, forms, statements and other documents required to           be filed
by it with the SEC pursuant to the reporting requirements of the 1934           Act (all
of the foregoing filed prior to the date hereof and all exhibits           included
therein and financial statements, notes and schedules thereto and           documents
incorporated by reference therein being hereinafter referred to as the           “SEC
Documents”). The Company has delivered to the Buyers or           their
respective representatives true, correct and complete copies of the SEC
          Documents not available on the EDGAR system. As of their respective dates, the
          SEC Documents complied in all material respects with the requirements of the
          1934 Act and the rules and regulations of the SEC promulgated thereunder
          applicable to the SEC Documents, and none of the SEC Documents, at the time
they           were filed with the SEC, contained any untrue statement of a material fact
or           omitted to state a material fact required to be stated therein or necessary
in           order to make the statements therein, in the light of the circumstances
under           which they were made, not misleading. As of their respective dates, the
          financial statements of the Company included in the SEC Documents complied as
to           form in all material respects with applicable accounting requirements and
the           published rules and regulations of the SEC with respect thereto. Such
financial           statements have been prepared in accordance with generally accepted
accounting           principles, consistently applied, during the periods involved
(except (i) as may           be otherwise indicated in such financial statements or the
notes thereto, or           (ii) in the case of unaudited interim statements, to the
extent they may exclude           footnotes or may be condensed or summary statements)
and fairly present in all           material respects the financial position of the
Company as of the dates thereof           and the results of its operations and cash
flows for the periods then ended           (subject, in the case of unaudited statements,
to normal year-end audit           adjustments). No other information provided by or on
behalf of the Company to           the Buyers which is not included in the SEC Documents,
including, without           limitation, information referred to in Section 2(d) of this
Agreement, contains           any untrue statement of a material fact or omits to state
any material fact           necessary in order to make the statements therein, in the
light of the           circumstance under which they are or were made, not misleading.  

9 

    
          (l)           Absence
of Certain Changes. Except as disclosed in Schedule 3(l),           since
September 30, 2007, there has been no material adverse change and no           material
adverse development in the business, properties, operations, condition
          (financial or otherwise), results of operations or prospects of the Company or
          its Subsidiaries. Except as disclosed in Schedule 3(l), since September
          30, 2007, the Company has not (i) declared or paid any dividends, (ii) sold any
          assets, individually or in the aggregate, in excess of $100,000 outside of the
          ordinary course of business or (iii) had capital expenditures, individually or
          in the aggregate, in excess of $100,000. Neither the Company nor any of its
          Subsidiaries has taken any steps to seek protection pursuant to any bankruptcy
          law nor does the Company have any knowledge or reason to believe that its
          creditors intend to initiate involuntary bankruptcy proceedings or any actual
          knowledge of any fact which would reasonably lead a creditor to do so. The
          Company is not as of the date hereof, and after giving effect to the
          transactions contemplated hereby to occur at the Closing, will not be Insolvent
          (as defined below). For purposes of this Section 3(l), “Insolvent”          means,
with respect to any Person (as defined in Section 3(s), (i) the present           fair
saleable value of such Person’s assets is less than the amount           required to
pay such Person’s total Indebtedness (as defined in Section           3(s)), (ii)
such Person is unable to pay its debts and liabilities,           subordinated,
contingent or otherwise, as such debts and liabilities become           absolute and
matured, (iii) the Company intends to incur or believes that it           will incur
debts that would be beyond its ability to pay as such debts mature or           (iv) such
Person has unreasonably small capital with which to conduct the           business in
which it is engaged as such business is now conducted and is           proposed to be
conducted.  

    
          (m)           No
Undisclosed Events, Liabilities, Developments or Circumstances. No           event,
liability, development or circumstance has occurred or exists, or is
          contemplated to occur with respect to the Company, its Subsidiaries or their
          respective business, properties, prospects, operations or financial condition,
          that would be required to be disclosed by the Company under applicable
          securities laws on a registration statement on Form S-1 filed with the SEC
          relating to an issuance and sale by the Company of its Common Stock and which
          has not been publicly announced.  

10 

    
          (n)           Conduct
of Business; Regulatory Permits. Neither the Company nor its           Subsidiaries
is in violation of any term of or in default under any certificate           of
designations of any outstanding series of preferred stock of the Company, its
          Articles of Incorporation or Bylaws or their organizational charter or
          certificate of incorporation or bylaws, respectively. Neither the Company nor
          any of its Subsidiaries is in violation of any judgment, decree or order or any
          statute, ordinance, rule or regulation applicable to the Company or its
          Subsidiaries, and neither the Company nor any of its Subsidiaries will conduct
          its business in violation of any of the foregoing, except for possible
          violations which would not, individually or in the aggregate, have a Material
          Adverse Effect. Without limiting the generality of the foregoing, the Company
is           not in violation of any of the rules, regulations or requirements of the
          Principal Market and has no knowledge of any facts or circumstances which would
          reasonably lead to delisting or suspension of the Common Stock by the Principal
          Market in the foreseeable future. During the two years prior to the date
hereof,           the Common Stock has been designated for quotation on the Principal
Market.           During the two years prior to the date hereof, (i) trading in the
Common Stock           has not been suspended by the SEC or the Principal Market and (ii)
the Company           has received no communication, written or oral, from the SEC or the
Principal           Market regarding the suspension or delisting of the Common Stock from
the           Principal Market. The Company and its Subsidiaries possess all
certificates,           authorizations and permits issued by the appropriate regulatory
authorities           necessary to conduct their respective businesses, except where the
failure to           possess such certificates, authorizations or permits would not have,
          individually or in the aggregate, a Material Adverse Effect, and neither the
          Company nor any such Subsidiary has received any notice of proceedings relating
          to the revocation or modification of any such certificate, authorization or
          permit.  

    
          (o)           Foreign
Corrupt Practices. Neither the Company, nor any of its           Subsidiaries, nor
any director, officer, agent, employee or other Person acting           on behalf of the
Company or any of its Subsidiaries has, in the course of its           actions for, or on
behalf of, the Company or any of its Subsidiaries (i) used           any corporate funds
for any unlawful contribution, gift, entertainment or other           unlawful expenses
relating to political activity; (ii) made any direct or           indirect unlawful
payment to any foreign or domestic government official or           employee from
corporate funds; (iii) violated or is in violation of any           provision of the U.S.
Foreign Corrupt Practices Act of 1977, as amended; or (iv)           made any unlawful
bribe, rebate, payoff, influence payment, kickback or other           unlawful payment to
any foreign or domestic government official or employee.  

    
          (p)           Sarbanes-Oxley
Act. The Company is in compliance with any and all           applicable requirements
of the Sarbanes-Oxley Act of 2002 that are effective as           of the date hereof, and
any and all applicable rules and regulations promulgated           by the SEC thereunder
that are effective as of the date hereof.  

    
          (q)           Transactions
With Affiliates. Except as set on Schedule 3(q), none           of the
officers, directors or employees of the Company is presently a party to           any
transaction with the Company or any of its Subsidiaries (other than for
          ordinary course services as employees, officers or directors), including any
          contract, agreement or other arrangement providing for the furnishing of
          services to or by, providing for rental of real or personal property to or
from,           or otherwise requiring payments to or from any such officer, director or
          employee or, to the knowledge of the Company or any of its Subsidiaries, any
          corporation, partnership, trust or other entity in which any such officer,
          director, or employee has a substantial interest or is an officer, director,
          trustee or partner.  

11 

    
          (r)           Equity
Capitalization. As of the date hereof, the authorized capital           stock of the
Company consists of (i) 200,000,000 shares of Common Stock, of           which as of the
date hereof, 44,373,813 are issued and outstanding, 8,200,000           shares are
reserved for issuance pursuant to the Company’s stock option and           purchase
plans and 12,245,452 shares are reserved for issuance pursuant to           securities
(other than the aforementioned options, the Notes and the Warrants)           exercisable
or exchangeable for, or convertible into, shares of Common Stock and           (ii)
20,000,000shares of preferred stock, par value $0.001 per share, of
          which as of the date hereof, none are issued and outstanding. All of such
          outstanding shares have been, or upon issuance will be, validly issued and are
          fully paid and nonassessable. Except as disclosed in Schedule 3(r): (i)
          none of the Company’s capital stock is subject to preemptive rights or any
          other similar rights or any liens or encumbrances suffered or permitted by the
          Company; (ii) there are no outstanding options, warrants, scrip, rights to
          subscribe to, calls or commitments of any character whatsoever relating to, or
          securities or rights convertible into, or exercisable or exchangeable for, any
          capital stock of the Company or any of its Subsidiaries, or contracts,
          commitments, understandings or arrangements by which the Company or any of its
          Subsidiaries is or may become bound to issue additional capital stock of the
          Company or any of its Subsidiaries or options, warrants, scrip, rights to
          subscribe to, calls or commitments of any character whatsoever relating to, or
          securities or rights convertible into, or exercisable or exchangeable for, any
          capital stock of the Company or any of its Subsidiaries; (iii) there are no
          outstanding debt securities, notes, credit agreements, credit facilities or
          other agreements, documents or instruments evidencing Indebtedness of the
          Company or any of its Subsidiaries or by which the Company or any of its
          Subsidiaries is or may become bound; (iv) there are no financing statements
          securing obligations in any material amounts, either singly or in the
aggregate,           filed in connection with the Company or any of its Subsidiaries; (v)
there are           no agreements or arrangements under which the Company or any of its
Subsidiaries           is obligated to register the sale of any of their securities under
the 1933 Act           (except pursuant to the Registration Rights Agreement); (vi) there
are no           outstanding securities or instruments of the Company or any of its
Subsidiaries           which contain any redemption or similar provisions, and there are
no contracts,           commitments, understandings or arrangements by which the Company
or any of its           Subsidiaries is or may become bound to redeem a security of the
Company or any           of its Subsidiaries; (vii) there are no securities or
instruments containing           anti-dilution or similar provisions that will be
triggered by the issuance of           the Securities; (viii) the Company does not have
any stock appreciation rights           or “phantom stock” plans or agreements
or any similar plan or           agreement; and (ix) the Company and its Subsidiaries
have no liabilities or           obligations required to be disclosed in the SEC
Documents but not so disclosed           in the SEC Documents, other than those incurred
in the ordinary course of the           Company’s or its Subsidiaries’ respective
businesses and which,           individually or in the aggregate, do not or would not
have a Material Adverse           Effect. The Company has furnished to the Buyers true,
correct and complete           copies of the Company’s Articles of Incorporation, as
amended and as in           effect on the date hereof (the “Articles of
Incorporation”),           and the Company’s Bylaws, as amended and as in
effect on the date hereof           (the “Bylaws”), and the terms of all
securities convertible           into, or exercisable or exchangeable for, shares of
Common Stock and the           material rights of the holders thereof in respect thereto.  

12 

    
          (s)           Indebtedness
and Other Contracts. Except as disclosed in Schedule           3(s), neither
the Company nor any of its Subsidiaries (i) has any           outstanding Indebtedness
(as defined below), (ii) is a party to any contract,           agreement or instrument,
the violation of which, or default under which, by the           other party(ies) to such
contract, agreement or instrument would result in a           Material Adverse Effect,
(iii) is in violation of any term of or in default           under any contract,
agreement or instrument relating to any Indebtedness, except           where such
violations and defaults would not result, individually or in the           aggregate, in
a Material Adverse Effect, or (iv) is a party to any contract,           agreement or
instrument relating to any Indebtedness, the performance of which,           in the
judgment of the Company’s officers, has or is expected to have a           Material
Adverse Effect. Schedule 3(s) provides a detailed description of           the
material terms of any such outstanding Indebtedness. For purposes of this
          Agreement: (x) “Indebtedness” of any Person means, without
          duplication (A) all indebtedness for borrowed money, (B) all obligations
issued,           undertaken or assumed as the deferred purchase price of property or
services,           including (without limitation) “capital leases” in
accordance with           generally accepted accounting principles (other than trade
payables entered into           in the ordinary course of business), (C) all
reimbursement or payment           obligations with respect to letters of credit, surety
bonds and other similar           instruments, (D) all obligations evidenced by notes,
bonds, debentures or           similar instruments, including obligations so evidenced
incurred in connection           with the acquisition of property, assets or businesses,
(E) all indebtedness           created or arising under any conditional sale or other
title retention           agreement, or incurred as financing, in either case with
respect to any property           or assets acquired with the proceeds of such
indebtedness (even though the           rights and remedies of the seller or bank under
such agreement in the event of           default are limited to repossession or sale of
such property), (F) all monetary           obligations under any leasing or similar
arrangement which, in connection with           generally accepted accounting principles,
consistently applied for the periods           covered thereby, is classified as a
capital lease, (G) all indebtedness referred           to in clauses (A) through (F)
above secured by (or for which the holder of such           Indebtedness has an existing
right, contingent or otherwise, to be secured by)           any mortgage, lien, pledge,
charge, security interest or other encumbrance upon           or in any property or
assets (including accounts and contract rights) owned by           any Person, even
though the Person which owns such assets or property has not           assumed or become
liable for the payment of such indebtedness, and (H) all           Contingent Obligations
in respect of indebtedness or obligations of others of           the kinds referred to in
clauses (A) through (G) above; (y) “Contingent           Obligation” means,
as to any Person, any direct or indirect liability,           contingent or otherwise, of
that Person with respect to any indebtedness, lease,           dividend or other
obligation of another Person if the primary purpose or intent           of the Person
incurring such liability, or the primary effect thereof, is to           provide
assurance to the obligee of such liability that such liability will be           paid or
discharged, or that any agreements relating thereto will be complied           with, or
that the holders of such liability will be protected (in whole or in           part)
against loss with respect thereto; and (z) “Person” means           an
individual, a limited liability company, a partnership, a joint venture, a
          corporation, a trust, an unincorporated organization and a government or any
          department or agency thereof.  

    
          (t)           Absence
of Litigation. There is no action, suit, proceeding, inquiry or
          investigation before or by the Principal Market, any court, public board,
          government agency, self-regulatory organization or body pending or, to the
          knowledge of the Company, threatened against or affecting the Company or any of
          its Subsidiaries, the Common Stock or any of the Company’s Subsidiaries or
          any of the Company’s or its Subsidiaries’ officers or directors in
          their capacities as such, except as set forth in Schedule 3(t).  

13 

    
          (u)           Insurance.
The Company and each of its Subsidiaries are insured by           insurers of recognized
financial responsibility against such losses and risks           and in such amounts as
management of the Company believes to be prudent and           customary in the
businesses in which the Company and its Subsidiaries are           engaged. Neither the
Company nor any such Subsidiary has been refused any           insurance coverage sought
or applied for and neither the Company nor any such           Subsidiary has any reason
to believe that it will not be able to renew its           existing insurance coverage as
and when such coverage expires or to obtain           similar coverage from similar
insurers as may be necessary to continue its           business at a cost that would not
have a Material Adverse Effect.  

    
          (v)           Employee
Relations. (i) Neither the Company nor any of its Subsidiaries           is a party
to any collective bargaining agreement or employs any member of a           union. The
Company and its Subsidiaries believe that their relations with their           employees
are good. No executive officer of the Company or any of its           Subsidiaries (as
defined in Rule 501(f) of the 1933 Act) has notified the           Company or any such
Subsidiary that such officer intends to leave the Company or           any such
Subsidiary or otherwise terminate such officer’s employment with           the
Company or any such Subsidiary. No executive officer of the Company or any           of
its Subsidiaries, to the knowledge of the Company, is, or is now expected to
          be, in violation of any material term of any employment contract,
          confidentiality, disclosure or proprietary information agreement,
          non-competition agreement, or any other contract or agreement or any
restrictive           covenant, and the continued employment of each such executive
officer does not           subject the Company or any of its Subsidiaries to any
liability with respect to           any of the foregoing matters.  

    
          
          (ii)                     The
Company and its Subsidiaries are in compliance with all federal, state,           local
and foreign laws and regulations respecting labor, employment and           employment
practices and benefits, terms and conditions of employment and wages           and hours,
except where failure to be in compliance would not, either           individually or in
the aggregate, reasonably be expected to result in a Material           Adverse Effect.  

    
          (w)           Title.
The Company and its Subsidiaries have good and marketable title in           fee simple
to all real property and good and marketable title to all personal           property
owned by them which is material to the business of the Company and its
          Subsidiaries, in each case free and clear of all liens, encumbrances and
defects           except such as do not materially affect the value of such property and
do not           interfere with the use made and proposed to be made of such property by
the           Company and any of its Subsidiaries. Any real property and facilities held
under           lease by the Company and any of its Subsidiaries are held by them under
valid,           subsisting and enforceable leases with such exceptions as are not
material and           do not interfere with the use made and proposed to be made of such
property and           buildings by the Company and its Subsidiaries.  

    
          (x)           Intellectual
Property Rights. The Company and its Subsidiaries own or           possess adequate
rights or licenses to use all trademarks, trade names, service           marks, service
mark registrations, service names, patents, patent rights,           copyrights,
inventions, licenses, approvals, governmental authorizations, trade           secrets and
other intellectual property rights (“Intellectual Property           Rights”)
necessary to conduct their respective businesses as now           conducted. Except as
set forth in Schedule 3(x), none of the           Company’s Intellectual
Property Rights have expired or terminated, or are           expected to expire or
terminate, within three years from the date of this           Agreement. The Company does
not have any knowledge of any infringement by the           Company or its Subsidiaries
of Intellectual Property Rights of others. There is           no claim, action or
proceeding being made or brought, or to the knowledge of the           Company or its
Subsidiaries, being threatened, against the Company or its           Subsidiaries
regarding its Intellectual Property Rights. The Company is unaware           of any facts
or circumstances which might give rise to any of the foregoing           infringements or
claims, actions or proceedings. The Company and its           Subsidiaries have taken
reasonable security measures to protect the secrecy,           confidentiality and value
of all of their intellectual properties.  

14 

    
          (y)           Environmental
Laws. The Company and its Subsidiaries (i) are in           compliance with any and
all Environmental Laws (as hereinafter defined), (ii)           have received all
permits, licenses or other approvals required of them under           applicable
Environmental Laws to conduct their respective businesses and (iii)           are in
compliance with all terms and conditions of any such permit, license or
          approval where, in each of the foregoing clauses (i), (ii) and (iii), the
          failure to so comply could be reasonably expected to have, individually or in
          the aggregate, a Material Adverse Effect. The term “Environmental
          Laws” means all federal, state, local or foreign laws relating to
          pollution or protection of human health or the environment (including, without
          limitation, ambient air, surface water, groundwater, land surface or subsurface
          strata), including, without limitation, laws relating to emissions, discharges,
          releases or threatened releases of chemicals, pollutants, contaminants, or
toxic           or hazardous substances or wastes (collectively, “Hazardous
          Materials”)into the environment, or otherwise relating to the
          manufacture, processing, distribution, use, treatment, storage, disposal,
          transport or handling of Hazardous Materials, as well as all authorizations,
          codes, decrees, demands or demand letters, injunctions, judgments, licenses,
          notices or notice letters, orders, permits, plans or regulations issued,
          entered, promulgated or approved thereunder.  

    
          (z)           Subsidiary
Rights. Except as set forth in Schedule 3(z), the           Company or one of
its Subsidiaries has the unrestricted right to vote, and           (subject to
limitations imposed by applicable law) to receive dividends and           distributions
on, all capital securities of its Subsidiaries as owned by the           Company or such
Subsidiary.  

    
          (aa)           Investment
Company Status. The Company is not, and upon consummation of           the sale of
the Securities will not be, an “investment company,” a           company
controlled by an “investment company” or an “affiliated           person” of,
or “promoter” or “principal underwriter”          for, an “investment
company” as such terms are defined in the           Investment Company Act of 1940,
as amended.  

    
          (bb)           Tax
Status. The Company and each of its Subsidiaries (i) has made or           filed all
foreign, federal and state income and all other tax returns, reports           and
declarations required by any jurisdiction to which it is subject, (ii) has           paid
all taxes and other governmental assessments and charges that are material           in
amount, shown or determined to be due on such returns, reports and
          declarations, except those being contested in good faith and (iii) has set
aside           on its books provision reasonably adequate for the payment of all taxes
for           periods subsequent to the periods to which such returns, reports or
declarations           apply. There are no unpaid taxes in any material amount claimed to
be due by the           taxing authority of any jurisdiction, and the officers of the
Company know of no           basis for any such claim.  

15 

    
          (cc)           Internal
Accounting and Disclosure Controls. The Company and each of its
          Subsidiaries maintain a system of internal accounting controls sufficient to
          provide reasonable assurance that (i) transactions are executed in accordance
          with management’s general or specific authorizations, (ii) transactions
are           recorded as necessary to permit preparation of financial statements in
          conformity with generally accepted accounting principles and to maintain asset
          and liability accountability, (iii) access to assets or incurrence of
          liabilities is permitted only in accordance with management’s general or
          specific authorization and (iv) the recorded accountability for assets and
          liabilities is compared with the existing assets and liabilities at reasonable
          intervals and appropriate action is taken with respect to any difference. The
          Company maintains disclosure controls and procedures (as such term is defined
in           Rule 13a-14 under the 1934 Act) that are effective in ensuring that
information           required to be disclosed by the Company in the reports that it
files or submits           under the 1934 Act is recorded, processed, summarized and
reported, within the           time periods specified in the rules and forms of the SEC,
including, without           limitation, controls and procedures designed in to ensure
that information           required to be disclosed by the Company in the reports that it
files or submits           under the 1934 Act is accumulated and communicated to the
Company’s           management, including its principal executive officer or
officers and its           principal financial officer or officers, as appropriate, to
allow timely           decisions regarding required disclosure. During the twelve months
prior to the           date hereof neither the Company nor any of its Subsidiaries have
received any           notice or correspondence from any accountant relating to any
material weakness           in any part of the system of internal accounting controls of
the Company or any           of its Subsidiaries  

    
          (dd)           Off
Balance Sheet Arrangements. There is no transaction, arrangement, or           other
relationship between the Company and an unconsolidated or other off           balance
sheet entity that is required to be disclosed by the Company in its           Exchange
Act filings and is not so disclosed or that otherwise would be           reasonably
likely to have a Material Adverse Effect.  

    
          (ee)           Ranking
of Notes. Except as set forth on Schedule 3(ee), no           Indebtedness of
the Company is senior to or ranks pari passu with the           Notes in right of
payment, whether with respect of payment of redemptions,           interest, damages or
upon liquidation or dissolution or otherwise.  

    
          (ff)           Form
S-1 Eligibility. The Company is eligible to register the Conversion           Shares,
the Interest Shares and the Warrant Shares for resale by the Buyers           using Form
S-1 promulgated under the 1933 Act.  

    
          (gg)           Transfer
Taxes. On the Closing Date, all stock transfer or other taxes           (other than
income or similar taxes) which are required to be paid in connection           with the
sale and transfer of the Securities to be sold to each Buyer hereunder           will be,
or will have been, fully paid or provided for by the Company, and all           laws
imposing such taxes will be or will have been complied with.  

    
          (hh)           Manipulation
of Price. The Company has not, and to its knowledge no one           acting on its
behalf has, (i) taken, directly or indirectly, any action designed           to cause or
to result in the stabilization or manipulation of the price of any           security of
the Company to facilitate the sale or resale of any of the           Securities, (ii)
other than the Placement Agent, sold, bid for, purchased, or           paid any
compensation for soliciting purchases of, any of the Securities, or           (iii) other
than the Placement Agent, paid or agreed to pay to any person any           compensation
for soliciting another to purchase any other securities of the           Company.  

16 

    
          (ii)           Acknowledgement
Regarding Buyers’ Trading Activity. It is understood           and acknowledged
by the Company that, except as set forth in Section 4(t), (i)           none of the
Buyers have been asked to agree, nor has any Buyer agreed, to desist           from
purchasing or selling, long and/or short, securities of the Company, or           “derivative” securities
based on securities issued by the Company or           to hold the Securities for any
specified term; (ii) any Buyer, and counter           parties in “derivative” transactions
to which any such Buyer is a           party, directly or indirectly, presently may have
a “short” position           in the Common Stock, and (iii) each Buyer shall
not be deemed to have any           affiliation with or control over any arm’s
length counter-party in any           “derivative” transaction. The Company
further understands and           acknowledges that one or more Buyers may engage in
hedging and/or trading           activities at various times during the period that the
Securities are           outstanding, including, without limitation, during the periods
that the value of           the Conversion Shares, the Warrant Shares, and the Interest
Shares are being           determined and (b) such hedging and/or trading activities, if
any, can reduce           the value of the existing stockholders’ equity interest in
the Company both           at and after the time the hedging and/or trading activities
are being conducted.           The Company acknowledges that such aforementioned hedging
and/or trading           activities do not constitute a breach of this Agreement, the
Notes, the Warrants           or any of the documents executed in connection herewith.  

    
          (jj)           U.S.
Real Property Holding Corporation. The Company is not, nor has ever           been, a
U.S. real property holding corporation within the meaning of Section 897           of the
Internal Revenue Code of 1986, as amended, and the Company shall so           certify
upon Buyer’s request.  

    
          (kk)           Bank
Holding Company Act. Neither the Company nor any of its Subsidiaries           is
subject to the Bank Holding Company Act of 1956, as amended (the           “BHCA”)
and to regulation by the Board of Governors of the           Federal Reserve System (the
“Federal Reserve”). Neither the           Company nor any of its
Subsidiaries or affiliates owns or controls, directly or           indirectly, five
percent (5%) or more of the outstanding shares of any class of           voting
securities or twenty-five (25%) or more of the total equity of a bank or           any
equity that is subject to the BHCA and to regulation by the Federal Reserve.
          Neither the Company nor any of its Subsidiaries or affiliates exercises a
          controlling influence over the management or policies of a bank or any entity
          that is subject to the BHCA and to regulation by the Federal Reserve.  

    
          (ll)           Disclosure.
The Company confirms that neither it nor any other Person           acting on its behalf
has provided any of the Buyers or their agents or counsel           with any information
that constitutes or could reasonably be expected to           constitute material,
nonpublic information. The Company understands and confirms           that each of the
Buyers will rely on the foregoing representations in effecting           transactions in
securities of the Company. All disclosure provided to the Buyers           regarding the
Company, or any of its Subsidiaries, their business and the           transactions
contemplated hereby, including the Schedules to this Agreement,           furnished by or
on behalf of the Company is true and correct and does not           contain any untrue
statement of a material fact or omit to state any material           fact necessary in
order to make the statements made therein, in the light of the           circumstances
under which they were made, not misleading. Each press release           issued by the
Company or any of its Subsidiaries during the twelve (12) months           preceding the
date of this Agreement did not at the time of release contain any           untrue
statement of a material fact or omit to state a material fact required to           be
stated therein or necessary in order to make the statements therein, in the
          light of the circumstances under which they were made, not misleading. No event
          or circumstance has occurred or information exists with respect to the Company
          or any of its Subsidiaries or its or their business, properties, prospects,
          operations or financial conditions, which, under applicable law, rule or
          regulation, requires public disclosure or announcement by the Company but which
          has not been so publicly announced or disclosed.  

17 

    4.                     COVENANTS.  

    
          (a)           Best
Efforts. Each party shall use its best efforts timely to satisfy           each of
the conditions to be satisfied by it as provided in Sections 6 and 7 of           this
Agreement.  

    
          (b)           Form
D and Blue Sky. The Company agrees to file a Form D with respect to           the
Securities as required under Regulation D and to provide a copy thereof to           each
Buyer promptly after such filing. The Company shall, on or before the           Closing
Date, take such action as the Company shall reasonably determine is           necessary
in order to obtain an exemption for or to qualify the Securities for           sale to
the Buyers at the Closing pursuant to this Agreement under applicable
          securities or “Blue Sky” laws of the states of the United States (or
          to obtain an exemption from such qualification), and shall provide evidence of
          any such action so taken to the Buyers on or prior to the Closing Date. The
          Company shall make all filings and reports relating to the offer and sale of
the           Securities required under applicable securities or “Blue Sky” laws
of           the states of the United States following the Closing Date.  

    
          (c)           Reporting
Status. Until the date on which the Investors (as defined in           the
Registration Rights Agreement) shall have sold all the Conversion Shares,           the
Interest Shares and the Warrant Sharesand none of the Notes orthe Warrants
is outstanding (the “Reporting Period”), the           Company shall
timely file all reports required to be filed with the SEC pursuant           to the 1934
Act, and the Company shall not terminate its status as an issuer           required to
file reports under the 1934 Act even if the 1934 Act or the rules           and
regulations thereunder would permit such termination.  

    
          (d)           Use
of Proceeds. The Company will use the proceeds from the sale of the
          Securities for general corporate and for working capital purposes and not for
          (i) the repayment of any outstanding Indebtedness of the Company or any of its
          Subsidiaries, (ii) the redemption or repurchase of any of its or its
          Subsidiaries’ equity securities or (iii) the settlement of any claims,
          actions or proceedings against the Company or any of its Subsidiaries.  

    
          (e)           Financial
Information. The Company agrees to send the following to each           Investor (as
defined in the Registration Rights Agreement) during the Reporting           Period (i)
unless the following are filed with the SEC through EDGAR and are           available to
the public through the EDGAR system, within one (1) Business Day           after the
filing thereof with the SEC, a copy of its Annual Reports and           Quarterly Reports
on Form 10-K, 10-KSB, 10-Q or 10-QSB, any interim reports or           any consolidated
balance sheets, income statements, stockholders’ equity           statements and/or
cash flow statements for any period other than annual, any           Current Reports on
Form 8-K and any registration statements (other than on Form           S-8) or amendments
filed pursuant to the 1933 Act, (ii) on the same day as the           release thereof,
facsimile or e-mailed copies of all press releases issued by           the Company or any
of its Subsidiaries, and (iii) copies of any notices and           other information made
available or given to the stockholders of the Company           generally,
contemporaneously with the making available or giving thereof to the
          stockholders. As used herein, “Business Day” means any day
          other than Saturday, Sunday or other day on which commercial banks in The City
          of New York are authorized or required by law to remain closed.  

18 

    
          (f)           Listing.
The Company shall promptly secure the listing of all of the           Registrable
Securities (as defined in the Registration Rights Agreement) upon           each national
securities exchange and automated quotation system, if any, upon           which the
Common Stock is then listed (subject to official notice of issuance)           and shall
maintain such listing of all Registrable Securities from time to time           issuable
under the terms of the Transaction Documents. The Company shall           maintain the
Common Stocks’ authorization for quotation on the Principal           Market.
Neither the Company nor any of its Subsidiaries shall take any action           which
would be reasonably expected to result in the delisting or suspension of           the
Common Stock on the Principal Market. The Company shall pay all fees and
          expenses in connection with satisfying its obligations under this Section 4(f).  

    
          (g)           Fees.
The Company shall reimburse Castlerigg (a Buyer) or its designee(s)           (in
addition to any other expense amounts paid to any Buyer prior to the date of
          this Agreement) for all reasonable costs and expenses incurred in connection
          with the transactions contemplated by the Transaction Documents (including all
          reasonable legal fees and disbursements in connection therewith, documentation
          and implementation of the transactions contemplated by the Transaction
Documents           and due diligence in connection therewith), which amount shall be
withheld by           such Buyer from its Net Purchase Price at the Closing. The Company
shall be           responsible for the payment of any placement agent’s fees,
financial           advisory fees, or broker’s commissions (other than for Persons
engaged by           any Buyer) relating to or arising out of the transactions
contemplated hereby,           including, without limitation, any fees or commissions
payable to the Placement           Agent. The Company shall pay, and hold each Buyer
harmless against, any           liability, loss or expense (including, without
limitation, reasonable           attorney’s fees and out-of-pocket expenses) arising
in connection with any           claim relating to any such payment. Except as otherwise
set forth in the           Transaction Documents, each party to this Agreement shall bear
its own expenses           in connection with the sale of the Securities to the Buyers.  

    
          (h)           Pledge
of Securities. The Company acknowledges and agrees that the           Securities may
be pledged by an Investor (as defined in the Registration Rights           Agreement) in
connection with a bona fide margin agreement or other loan or           financing
arrangement that is secured by the Securities. The pledge of           Securities shall
not be deemed to be a transfer, sale or assignment of the           Securities hereunder,
and no Investor effecting a pledge of Securities shall be           required to provide
the Company with any notice thereof or otherwise make any           delivery to the
Company pursuant to this Agreement or any other Transaction           Document,
including, without limitation, Section 2(f) hereof; provided that an           Investor
and its pledgee shall be required to comply with the provisions of           Section 2(f)
hereof in order to effect a sale, transfer or assignment of           Securities to such
pledgee. The Company hereby agrees to execute and deliver           such documentation as
a pledgee of the Securities may reasonably request in           connection with a pledge
of the Securities to such pledgee by an Investor.  

19 

    
          (i)           Disclosure
of Transactions and Other Material Information. On or before           8:30 a.m., New
York City time, on the first Business Day following the date of           this Agreement,
the Company shall issue a press release and file a Current           Report on Form 8-K
describing the terms of the transactions contemplated by the           Transaction
Documents in the form required by the 1934 Act and attaching the           material
Transaction Documents (including, without limitation, this Agreement,           the form
of the Notes, the form of Warrant, the form the Registration Rights           Agreement
and the form of Security Documents as exhibits to such filing           (including all
attachments, the “8-K Filing”). From and after           the filing of
the 8-K Filing with the SEC, no Buyer shall be in possession of           any material,
nonpublic information received from the Company, any of its           Subsidiaries or any
of their respective officers, directors, employees or           agents, that is not
disclosed in the 8-K Filing. The Company shall not, and           shall cause each of its
Subsidiaries and its and each of their respective           officers, directors,
employees and agents, not to, provide any Buyer with any           material, nonpublic
information regarding the Company or any of its Subsidiaries           from and after the
filing of the 8-K Filing with the SEC without the express           written consent of
such Buyer. If a Buyer has, or believes it has, received any           such material,
nonpublic information regarding the Company or any of its           Subsidiaries, it
shall provide the Company with written notice thereof. The           Company shall,
within two (2) Trading Days (as defined in the Notes) of receipt           of such
notice, make public disclosure of such material, nonpublic information.           In the
event of a breach of the foregoing covenant by the Company, any of its
          Subsidiaries, or any of its or their respective officers, directors, employees
          and agents, in addition to any other remedy provided herein or in the
          Transaction Documents, a Buyer shall have the right to make a public
disclosure,           in the form of a press release, public advertisement or otherwise,
of such           material, nonpublic information without the prior approval by the
Company, its           Subsidiaries, or any of its or their respective officers,
directors, employees           or agents. No Buyer shall have any liability to the
Company, its Subsidiaries,           or any of its or their respective officers,
directors, employees, stockholders           or agents for any such disclosure. Subject
to the foregoing, neither the           Company, its Subsidiaries nor any Buyer shall
issue any press releases or any           other public statements with respect to the
transactions contemplated hereby;           provided, however, that the Company shall be
entitled, without the prior           approval of any Buyer, to make any press release or
other public disclosure with           respect to such transactions (i) in substantial
conformity with the 8-K Filing           and contemporaneously therewith and (ii) as is
required by applicable law and           regulations (provided that in the case of clause
(i) each Buyer shall be           consulted by the Company in connection with any such
press release or other           public disclosure prior to its release). Without the
prior written consent of           any applicable Buyer, neither the Company nor any of
its Subsidiaries or           affiliates shall disclose the name of such Buyer in any
filing, announcement,           release or otherwise.  

    
          (j)           Restriction
on Redemption and Cash Dividends. So long as any Notes are           outstanding, the
Company shall not, directly or indirectly, redeem, or declare           or pay any cash
dividend or distribution on, the Common Stock without the prior           express written
consent of the holders of Notes representing not less than a           majority of the
aggregate principal amount of the then outstanding Notes.  

    
          (k)           Additional
Notes; Variable Securities; Dilutive Issuances. So long as any           Buyer
beneficially owns any Securities, the Company will not issue any Notes           other
than to the Buyers as contemplated hereby and the Company shall not issue           any
other securities that would cause a breach or default under the Notes. For           so
long as any Notes or Warrants remain outstanding, the Company shall not, in           any
manner, issue or sell any rights, warrants or options to subscribe for or
          purchase Common Stock or directly or indirectly convertible into or
exchangeable           or exercisable for Common Stock at a price which varies or may
vary with the           market price of the Common Stock, including by way of one or more
reset(s) to           any fixed price unless the conversion, exchange or exercise price
of any such           security cannot be less than the then applicable Conversion Price
(as defined in           the Notes) with respect to the Common Stock into which any Note
is convertible           or the then applicable Exercise Price (as defined in the
Warrants) with respect           to the Common Stock into which any Warrant is
exercisable. For so long as any           Notes or Warrants remain outstanding, the
Company shall not, in any manner,           enter into or affect any Dilutive Issuance
(as defined in the Notes) if the           effect of such Dilutive Issuance is to cause
the Company to be required to issue           upon conversion of any Note or exercise of
any Warrant any shares of Common           Stock in excess of that number of shares of
Common Stock which the Company may           issue upon conversion of the Notes and
exercise of the Warrants without           breaching the Company’s obligations under
the rules or regulations of the           Principal Market or any applicable Eligible
Market (as defined in the           Registration Rights Agreement).  

20 

    
          (l)       Corporate
Existence. So long as any Buyer beneficially owns any           Securities, the
Company shall not be party to any Fundamental Transaction (as           defined in the
Notes) unless the Company is in compliance with the applicable           provisions
governing Fundamental Transactions set forth in the Notes and the           Warrants.  

    
          (m)       Reservation
of Shares. So long as any Buyer owns any Securities, the           Company shall take
all action necessary to at all times have authorized, and           reserved for the
purpose of issuance, no less than 130% of the sum of the number           of shares of
Common Stock issuable (i) as Interest Shares pursuant to the terms           of the
Notes, (ii) upon conversion of the Notes and (ii) upon exercise of the           Warrants
then outstanding (without taking into account any limitations on the           conversion
of the Notes or exercise of the Warrants set forth in the Notes and           Warrants,
respectively).  

    
          (n)       Conduct
of Business. The business of the Company and its Subsidiaries           shall not be
conducted in violation of any law, ordinance or regulation of any           governmental
entity, except where such violations would not result, either           individually or
in the aggregate, in a Material Adverse Effect.  

    
          (o)       Additional
Issuances of Securities.  

    
          
          (i)       For
purposes of this Section 4(o), the following definitions shall apply.  

    
          
          
          (1)       “Convertible
Securities” means any stock or securities (other           than Options)
convertible into or exercisable or exchangeable for shares of           Common Stock.  

    
          
          
          (2)       “Options” means
any rights, warrants or options to subscribe           for or purchase shares of Common
Stock or Convertible Securities.  

    
          
          
          (3)       “Common
Stock Equivalents” means, collectively, Options and           Convertible
Securities.  

21 

    
          
          (ii)       From
the date hereof until the date when all Registrable Securities (as defined           in
the Registration Rights Agreement) are freely tradable without the           requirement
to be in compliance with Rule 144(c)(1) and otherwise without           restriction or
limitation pursuant to Rule 144 (the “Trigger           Date”), the
Company will not, directly or indirectly, file any           registration statement with
the SEC other than the Registration Statement (as           defined in the Registration
Rights Agreement). From the date hereof until the           Trigger Date, the Company
will not, (i) directly or indirectly, offer, sell,           grant any option to
purchase, or otherwise dispose of (or announce any offer,           sale, grant or any
option to purchase or other disposition of) any of its or its           Subsidiaries’ equity
or equity equivalent securities, including without           limitation any debt,
preferred stock or other instrument or security that is, at           any time during its
life and under any circumstances, convertible into or           exchangeable or
exercisable for shares of Common Stock or Common Stock           Equivalents (any such
offer, sale, grant, disposition or announcement being           referred to as a “Subsequent
Placement”) or (ii) be party to           any solicitations, negotiations or
discussions with regard to the foregoing.  

    
          
          (iii)       From
the Trigger Date until the third anniversary of the earlier of (i) the date
          when all Registrable Securities (as defined in the Registration Rights
          Agreement) have been registered or (ii) the date when all Registrable
Securities           are freely tradable without the requirement to be in compliance with
Rule           144(c)(1) and otherwise without restriction or limitation pursuant to Rule
144,           the Company will not, directly or indirectly, effect any Subsequent
Placement           unless the Company shall have first complied with this Section
4(o)(iii).  

		    
          
          (1)              The
Company shall deliver to each Buyer an irrevocable written notice           (the “Offer
Notice”) of any proposed or intended issuance           or sale or exchange (the “Offer”)
of the securities being           offered (the “Offered Securities”) in
a Subsequent Placement,           which Offer Notice shall (w) identify and describe the
Offered Securities,           (x) describe the price and other terms upon which they
are to be issued,           sold or exchanged, and the number or amount of the Offered
Securities to be           issued, sold or exchanged, (y) identify the persons or
entities (if known)           to which or with which the Offered Securities are to be
offered, issued, sold or           exchanged and (z) offer to issue and sell to or
exchange with such Buyers all of           the Offered Securities, allocated among such
Buyers (a) based on such           Buyer’s pro rata portion of the aggregate
principal amount of Notes           purchased hereunder (the “Basic Amount”),
and (b) with respect           to each Buyer that elects to purchase its Basic Amount,
any additional portion           of the Offered Securities attributable to the Basic
Amounts of other Buyers as           such Buyer shall indicate it will purchase or
acquire should the other Buyers           subscribe for less than their Basic Amounts
(the “Undersubscription Amount”), which process shall be repeated
until the Buyers shall           have an opportunity to subscribe for any remaining
Undersubscription Amount.  

		    
          
          (2)       To
accept an Offer, in whole or in part, such Buyer must deliver a written           notice
to the Company prior to the end of the tenth (10th) Business           Day
after such Buyer’s receipt of the Offer Notice (the “Offer Period”),
setting forth the portion of such Buyer’s Basic           Amount that such Buyer
elects to purchase and, if such Buyer shall elect to           purchase all of its Basic
Amount, the Undersubscription Amount, if any, that           such Buyer elects to
purchase (in either case, the “Notice of           Acceptance”). If the
Basic Amounts subscribed for by all Buyers are           less than the total of all of
the Basic Amounts, then each Buyer who has set           forth an Undersubscription
Amount in its Notice of Acceptance shall be entitled           to purchase, in addition
to the Basic Amounts subscribed for, the           Undersubscription Amount it has
subscribed for; provided, however,           that if the Undersubscription
Amounts subscribed for exceed the difference           between the total of all the Basic
Amounts and the Basic Amounts subscribed for           (the “Available Undersubscription
Amount”), each Buyer           who has subscribed for any Undersubscription
Amount shall be entitled to           purchase only that portion of the Available
Undersubscription Amount as the           Basic Amount of such Buyer bears to the total
Basic Amounts of all Buyers that           have subscribed for Undersubscription Amounts,
subject to rounding by the           Company to the extent its deems reasonably
necessary. Notwithstanding anything           to the contrary contained herein, if the
Company desires to modify or amend the           terms and conditions of the Offer prior
to the expiration of the Offer Period,           the Company may deliver to the Buyers a
new Offer Notice and the Offer Period           shall expire on the tenth (10th) Business
Day after such Buyer’s receipt of           such new Offer Notice.  

22 

		    
          
          (3)       The
Company shall have five (5) Business Days from the expiration of the Offer
          Period above to offer, issue, sell or exchange all or any part of such Offered
          Securities as to which a Notice of Acceptance has not been given by the Buyers
          (the “Refused Securities”), but only to the offerees described
          in the Offer Notice (if so described therein) and only upon terms and
conditions           (including, without limitation, unit prices and interest rates) that
are not           more favorable to the acquiring person or persons or less favorable to
the           Company than those set forth in the Offer Notice and (ii) to publicly
announce           (a) the execution of such Subsequent Placement Agreement, and (b)
either (x) the           consummation of the transactions contemplated by such Subsequent
Placement           Agreement or (y) the termination of such Subsequent Placement
Agreement, which           shall be filed with the SEC on a Current Report on Form 8-K
with such Subsequent           Placement Agreement and any documents contemplated therein
filed as exhibits           thereto.  

		    
          
          (4)       In
the event the Company shall propose to sell less than all the Refused
          Securities (any such sale to be in the manner and on the terms specified in
          Section 4(o)(iii)(3) above), then each Buyer may, at its sole option and in its
          sole discretion, reduce the number or amount of the Offered Securities
specified           in its Notice of Acceptance to an amount that shall be not less than
the number           or amount of the Offered Securities that such Buyer elected to
purchase pursuant           to Section 4(o)(iii)(2) above multiplied by a fraction, (i)
the numerator of           which shall be the number or amount of Offered Securities the
Company actually           proposes to issue, sell or exchange (including Offered
Securities to be issued           or sold to Buyers pursuant to Section 4(o)(iii)(3)
above prior to such           reduction) and (ii) the denominator of which shall be the
original amount of the           Offered Securities. In the event that any Buyer so
elects to reduce the number           or amount of Offered Securities specified in its
Notice of Acceptance, the           Company may not issue, sell or exchange more than the
reduced number or amount           of the Offered Securities unless and until such
securities have again been           offered to the Buyers in accordance with Section 4(o)(iii)(1)
above.  

		    
          
          (5)       Upon
the closing of the issuance, sale or exchange of all or less than all of           the
Refused Securities, the Buyers shall acquire from the Company, and the           Company
shall issue to the Buyers, the number or amount of Offered Securities           specified
in the Notices of Acceptance, as reduced pursuant to Section           4(o)(iii)(3) above
if the Buyers have so elected, upon the terms and conditions           specified in the
Offer. The purchase by the Buyers of any Offered Securities is           subject in all
cases to the preparation, execution and delivery by the Company           and the Buyers
of a purchase agreement relating to such Offered Securities           reasonably
satisfactory in form and substance to the Buyers and their respective           counsel.  

23 

		    
          
          (6)       Any
Offered Securities not acquired by the Buyers or other persons in accordance
          with Section 4(o)(iii)(3) above may not be issued, sold or exchanged until they
          are again offered to the Buyers under the procedures specified in this
          Agreement.  

		    
          
          (7)       The
Company and the Buyers agree that if any Buyer elects to participate in the
          Offer, (x) neither the agreement regarding the Subsequent Placement (the
          “Subsequent Placement Agreement”) with respect to such Offer
          nor any other transaction documents related thereto (collectively, the
          “Subsequent Placement Documents”) shall include any
          term or provisions whereby any Buyer shall be required to agree to any
          restrictions in trading as to any securities of the Company owned by such Buyer
          prior to such Subsequent Placement, and (y) any registration rights set forth
in           such Subsequent Placement Documents shall be similar in all material
respects to           the registration rights contained in the Registration Rights
Agreement.  

		    
          
          (8)       Notwithstanding
anything to the contrary in this Section 4(o) and unless           otherwise agreed to by
the Buyers, the Company shall either confirm in writing           to the Buyers that the
transaction with respect to the Subsequent Placement has           been abandoned or
shall publicly disclose its intention to issue the Offered           Securities, in
either case in such a manner such that the Buyers will not be in           possession of
material non-public information, by the fifteenth           (15th) Business
Day following delivery of the Offer Notice. If by the           fifteenth (15th)
Business Day following delivery of the Offer Notice           no public disclosure
regarding a transaction with respect to the Offered           Securities has been made,
and no notice regarding the abandonment of such           transaction has been received
by the Buyers, such transaction shall be deemed to           have been abandoned and the
Buyers shall not be deemed to be in possession of           any material, non-public
information with respect to the Company. Should the           Company decide to pursue
such transaction with respect to the Offered           Securities, the Company shall
provide each Buyer with another Offer Notice and           each Buyer will again have the
right of participation set forth in this Section           4(o)(iii). The Company shall
not be permitted to deliver more than one such           Offer Notice to the Buyers in
any 60 day period.  

    
          
          (iv)       The
restrictions contained in subsections (ii) and (iii) of this Section 4(o)           shall
not apply in connection with the issuance of any Excluded Securities (as
          defined in the Notes).  

24 

    
          (p)                     Each
Buyer hereby (a) appoints Castlerigg, as the collateral agent hereunder and
          under the other Security Documents (in such capacity, the “Collateral
          Agent”), and (b) authorizes the Collateral Agent (and its officers,
          directors, employees and agents) to take such action on such Buyer’s
behalf           in accordance with the terms hereof and thereof. The Collateral Agent
shall not           have, by reason hereof or any of the other Security Documents, a
fiduciary           relationship in respect of any Buyer. Neither the Collateral Agent
nor any of           its officers, directors, employees and agents shall have any
liability to any           Buyer for any action taken or omitted to be taken in
connection hereof or any           other Security Document except to the extent caused by
its own gross negligence           or willful misconduct, and each Buyer agrees to
defend, protect, indemnify and           hold harmless the Collateral Agent and all of
its officers, directors, employees           and agents (collectively, the “Indemnitees”)
from and against           any losses, damages, liabilities, obligations, penalties,
actions, judgments,           suits, fees, costs and expenses (including, without
limitation, reasonable           attorneys’ fees, costs and expenses) incurred by
such Indemnitee, whether           direct, indirect or consequential, arising from or in
connection with the           performance by such Indemnitee of the duties and
obligations of Collateral Agent           pursuant hereto or any of the Security
Documents. The Collateral Agent shall not           be required to exercise any
discretion or take any action, but shall be required           to act or to refrain from
acting (and shall be fully protected in so acting or           refraining from acting)
upon the instructions of the holders of at least a           majority in principal amount
of the Notes then outstanding, and such           instructions shall be binding upon all
holders of Notes; provided, however, that the Collateral Agent shall not be
required to take any           action which, in the reasonable opinion of the Agent,
exposes the Agent to           liability or which is contrary to this Agreement or any
other Transaction           Document or applicable law.  

    
          
          (i)                     The
Collateral Agent shall be entitled to rely upon any written notices,
          statements, certificates, orders or other documents or any telephone message
          believed by it in good faith to be genuine and correct and to have been signed,
          sent or made by the proper Person, and with respect to all matters pertaining
to           this Agreement or any of the other Transaction Documents and its duties
          hereunder or thereunder, upon advice of counsel selected by it.  

    
          
          (ii)                     The
Collateral Agent may resign from the performance of all its functions and
          duties hereunder and under the Notes and the Security Documents at any time by
          giving at least ten (10) Business Days prior written notice to the Company and
          each holder of the Notes. Such resignation shall take effect upon the
acceptance           by a successor Collateral Agent of appointment as provided below.
Upon any such           notice of resignation, the holders of a majority of the
outstanding principal           under the Notes shall appoint a successor Collateral
Agent. Upon the acceptance           of the appointment as Collateral Agent, such
successor Collateral Agent shall           succeed to and become vested with all the
rights, powers, privileges and duties           of the retiring Collateral Agent, and the
retiring Collateral Agent shall be           discharged from its duties and obligations
under this Agreement, the Notes and           the other Security Documents. After any
Collateral Agent’s resignation           hereunder , the provisions of this Section
4(p) shall inure to its benefit. If a           successor Collateral Agent shall not have
been so appointed within said ten (10)           Business Day period, the retiring
Collateral Agent shall then appoint a           successor Collateral Agent who shall
serve until such time, if any, as the           holders of a majority of the outstanding
principal under the Notes appoint a           successor Collateral Agent as provided
above.  

    
          (q)           No
Waiver of Lock-Up Agreements. The Company shall not amend, waive or           modify
any provision of any of the Lock-Up Agreements (as defined below).  

25 

    
          (r)           Public
Information. At any time during the period commencing on the six           (6) month
anniversary of the Closing Date and ending at such time that all of           the
Securities can be sold without the requirement to be in compliance with Rule
          144(c)(1) and otherwise without restriction or limitation pursuant to Rule 144,
          if a registration statement is not available for the resale of all of the
          Securities and the Company shall fail for any reason to satisfy the current
          public information requirement under Rule 144 (a “Public Information
          Failure”) then, as partial relief for the damages to any holder of
          Securities by reason of any such delay in or reduction of its ability to sell
          the Securities (which remedy shall not be exclusive of any other remedies
          available at law or in equity), the Company shall pay to each such holder an
          amount in cash equal to two percent (2.0%) of the aggregate Purchase Price of
          such holder’s Securities on the day of a Public Information Failure and on
          every thirtieth day (pro rated for periods totaling less than thirty days)
          thereafter until the earlier of (i) the date such Public Information Failure is
          cured and (ii) such time that such public information is no longer required
          pursuant to Rule 144. The payments to which a holder shall be entitled pursuant
          to this Section 4(p) are referred to herein as “Public Information Failure
          Payments.” Public Information Failure Payments shall be paid on the
earlier           of (I) the last day of the calendar month during which such Public
Information           Failure Payments are incurred and (II) the third Business Day after
the event or           failure giving rise to the Public Information Failure Payments is
cured. In the           event the Company fails to make Public Information Failure
Payments in a timely           manner, such Public Information Failure Payments shall
bear interest at the rate           of 1.5% per month (prorated for partial months) until
paid in full.  

    
          (s)           Trading
in Common Stock. For the period commencing on the date hereof and           ending on
the earlier to occur of (i) the six month anniversary of the Closing           Date and
(ii) the Effective Date (as defined in the Registration Rights           Agreement), each
Buyer, severally and not jointly with the other Buyers,           covenants that neither
it nor any affiliate acting on its behalf or pursuant to           any understanding with
it will engage in hedging activities with respect to the           Common Stock,
including “short sales” as defined in Rule 200 of           Regulation SHO
under the 1934 Act. With respect to any Buyer, for so long as           such Buyer owns
any Notes, such Buyer shall not maintain a Net Short Position.           For purposes of
this Section, a “Net Short Position” by a Buyer           means a
position whereby such Buyer has executed one or more sales of Common           Stock that
is marked as a short sale and that is executed at a time when such           Buyer has no
equivalent offsetting long position in the Common Stock or contract           for the
foregoing. For purposes of determining whether a Buyer has an equivalent
          offsetting long position in the Common Stock, all Common Stock (i) that is
owned           by such Buyer or (ii) that would be issuable upon conversion or exercise
in full           of all Securities then held by such Buyer (assuming that such
Securities were           then fully convertible or exercisable, notwithstanding any
provisions to the           contrary, and giving effect to any conversion or exercise
price adjustments that           would take effect given only the passage of time) shall
be deemed to be held           long by such Buyer.  

    
          (t)           Additional
Relief. If the Company shall fail for any reason or for no           reason to issue
to the Buyer unlegended certificates or issue Common Stock to           such Buyer by
electronic delivery at the applicable balance account at DTC           within three (3)
Trading Days after the receipt of documents necessary for the           removal of the
legend set forth in Section 2(g) above (the “Removal           Date”),
then in addition to all other remedies available to the Buyer,           if on or after
the Trading Day immediately following such three Trading Day           period, the Buyer
purchases (in an open market transaction or otherwise) shares           of Common Stock
to deliver in satisfaction of a sale by the Buyer of such Common           Stock that the
Buyer anticipated receiving without legend from the Company (a “Buy-In”),
then the Company shall, within three (3) Business           Days after the Buyer’s
request and in the Buyer’s discretion, either           (i) pay cash to the Buyer in
an amount equal to the Buyer’s total purchase           price (including brokerage
commissions, if any) for the shares of Common Stock           so purchased (the “Buy-In
Price”), at which point the           Company’s obligation to deliver such
unlegended Common Stock shall           terminate, or (ii) promptly honor its obligation
to deliver to the Buyer such           unlegended Common Stock as provided above and pay
cash to the Buyer in an amount           equal to the excess (if any) of the Buy-In Price
over the product of (A) such           number of shares of Common Stock, times (B) the
Closing Bid Price (as defined in           the Warrants) on the Removal Date.  

26 

    
          (u)           Closing
Documents. On or prior to fourteen (14) calendar days after the           Closing
Date, the Company agrees to deliver, or cause to be delivered, to each           Buyer
and Schulte Roth & Zabel LLP executed copies of the Transaction           Documents,
Securities and other document required to be delivered to any party           pursuant to
Section 7 hereof.  

    5.                     REGISTER;
TRANSFER AGENT INSTRUCTIONS.  

    
          (a)           Register.
The Company shall maintain at its principal executive offices           (or such other
office or agency of the Company as it may designate by notice to           each holder of
Securities), a register for the Notes and the Warrants in which           the Company
shall record the name and address of the Person in whose name the           Notes andthe
Warrants have been issued (including the name and address           of each transferee),
the principal amount of Notes held by such Person, the           number of Conversion
Shares issuable upon conversion of the Notes and the number           of Warrant Shares
issuable upon exercise of the Warrants held by such Person.           The Company shall
keep the register open and available at all times during           business hours for
inspection of any Buyer or its legal representatives.  

    
          (b)           Transfer
Agent Instructions. The Company shall issue irrevocable           instructions to its
transfer agent, and any subsequent transfer agent, to issue           certificates or
credit shares to the applicable balance accounts at The           Depository Trust
Company (“DTC”), registered in the name of           each Buyer or its
respective nominee(s), for the Conversion Shares, the Interest           Shares and the
Warrant Shares issued at the Closing or upon conversion of the           Notes or
exercise of the Warrants in such amounts as specified in such amounts           as
specified from time to time by each Buyer to the Company upon conversion of           the
Notes or exercise of the Warrants in the form of Exhibit G (the “Irrevocable
Transfer Agent Instructions”). The Company           warrants that no
instruction other than the Irrevocable Transfer Agent           Instructions referred to
in this Section 5(b), and stop transfer instructions to           give effect to Section
2(g) hereof, will be given by the Company to its transfer           agent, and that the
Securities shall otherwise be freely transferable on the           books and records of
the Company as and to the extent provided in this Agreement           and the other
Transaction Documents. If a Buyer effects a sale, assignment or           transfer of the
Securities in accordance with Section 2(f), the Company shall           permit the
transfer and shall promptly instruct its transfer agent to issue one           or more
certificates or credit shares to the applicable balance accounts at DTC           in such
name and in such denominations as specified by such Buyer to effect such           sale,
transfer or assignment. In the event that such sale, assignment or           transfer
involves Conversion Shares, Interest Shares or Warrant Shares sold,           assigned or
transferred pursuant to an effective registration statement or           pursuant to Rule
144, the transfer agent shall issue such Securities to the           Buyer, assignee or
transferee, as the case may be, without any restrictive           legend. The Company
acknowledges that a breach by it of its obligations           hereunder will cause
irreparable harm to a Buyer. Accordingly, the Company           acknowledges that the
remedy at law for a breach of its obligations under this           Section 5(b) will be
inadequate and agrees, in the event of a breach or           threatened breach by the
Company of the provisions of this Section 5(b), that a           Buyer shall be entitled,
in addition to all other available remedies, to an           order and/or injunction
restraining any breach and requiring immediate issuance           and transfer, without
the necessity of showing economic loss and without any           bond or other security
being required.  

27 

    6.                     CONDITIONS
TO THE COMPANY’S OBLIGATION TO SELL.  

        
          The
obligation of the Company hereunder to issue and sell the Notes and the related Warrants
to each Buyer at the Closing is subject to the satisfaction, at or before the Closing
Date, of each of the following conditions, provided that these conditions are for the
Company’s sole benefit and may be waived by the Company at any time in its sole
discretion by providing each Buyer with prior written notice thereof: 

    
          
          (i)                     Such
Buyer shall have executed each of the Transaction Documents to which it is           a
party and delivered the same to the Company.  

    
          
          (ii)                     Such
Buyer and each other Buyer shall have delivered to the Company the Net           Purchase
Price (less, in the case of Castlerigg, the amounts withheld pursuant           to
Section 4(g)) for the Notes and the related Warrants being purchased by such
          Buyer at the Closing by wire transfer of immediately available funds pursuant
to           the wire instructions provided by the Company.  

    
          
          (iii)                     The
representations and warranties of such Buyer shall be true and correct in           all
material respects as of the date when made and as of the Closing Date as           though
made at that time (except for representations and warranties that speak           as of a
specific date), and such Buyer shall have performed, satisfied and           complied in
all material respects with the covenants, agreements and conditions           required by
this Agreement to be performed, satisfied or complied with by such           Buyer at or
prior to the Closing Date.  

    7.                     CONDITIONS
TO EACH BUYER’S OBLIGATION TO PURCHASE.  

        
          The
obligation of each Buyer hereunder to purchase the Notes and the related Warrants
at the Closing is subject to the satisfaction, at or before the Closing Date, of each of
the following conditions, provided that these conditions are for each Buyer’s sole
benefit and may be waived by such Buyer at any time in its sole discretion by providing
the Company with prior written notice thereof: 

    
          
          (i)                     The
Company shall have duly executed and delivered to such Buyer (A) each of the
          Transaction Documents, (B) the Notes (in such principal amounts as such Buyer
          shall request), being purchased by such Buyer at the Closing pursuant to this
          Agreement, and (C) the related Warrants (in such amounts as such Buyer shall
          request) being purchased by such Buyer at the Closing pursuant to this
          Agreement.  

28 

    
          
          (ii)                     Such
Buyer shall have received the opinion of Dennis Brovarone, the           Company’s
outside counsel, dated as of the Closing Date, in substantially           the form of Exhibit
G attached hereto.  

    
          
          (iii)                     The
Company shall have delivered to such Buyer a copy of the Irrevocable           Transfer
Agent Instructions, in the form of Exhibit H attached hereto,           which
instructions shall have been delivered to and acknowledged in writing by           the
Company’s transfer agent.  

    
          
          (iv)                     The
Company shall have delivered to such Buyer a certificate evidencing the
          formation and good standing of the Company and each of its Subsidiaries in such
          entity’s jurisdiction of formation issued by the Secretary of State (or
          comparable office) of such jurisdiction, as of a date within 10 days of the
          Closing Date.  

    
          
          (v)                     The
Company shall have delivered to such Buyer a certificate evidencing the           Company’s
qualification as a foreign corporation and good standing issued           by the
Secretary of State (or comparable office) of each jurisdiction in which           the
Company conducts business, as of a date within 10 days of the Closing Date.  

    
          
          (vi)                     The
Company shall have delivered to such Buyer a certified copy of the Articles           of
Incorporation as certified by the Secretary of State of the State (or
          comparable office of Nevada within ten (10) days of the Closing Date.  

    
          
          (vii)                     The
Company shall have delivered to such Buyer a certificate, executed by the
          Secretary of the Company and dated as of the Closing Date, as to (i) the
          resolutions consistent with Section 3(b) as adopted by the Company’s Board
          of Directors in a form reasonably acceptable to such Buyer, (ii) the Articles
of           Incorporation and (iii) the Bylaws, each as in effect at the Closing, in the
          form attached hereto as Exhibit I.  

    
          
          (viii)                     The
representations and warranties of the Company shall be true and correct as           of
the date when made and as of the Closing Date as though made at that time
          (except for representations and warranties that speak as of a specific date)
and           the Company shall have performed, satisfied and complied in all respects
with           the covenants, agreements and conditions required by the Transaction
Documents           to be performed, satisfied or complied with by the Company at or
prior to the           Closing Date. Such Buyer shall have received a certificate,
executed by the           Chief Executive Officer of the Company, dated as of the Closing
Date, to the           foregoing effect and as to such other matters as may be reasonably
requested by           such Buyer in the form attached hereto as Exhibit J.  

    
          
          (ix)                     The
Company shall have delivered to such Buyer a letter from the Company’s
          transfer agent certifying the number of shares of Common Stock outstanding as
of           a date within five days of the Closing Date.  

    
          
          (x)                     The
Common Stock (I) shall be designated for quotation or listed on the           Principal
Market and (II) shall not have been suspended, as of the Closing Date,           by the
SEC or the Principal Market from trading on the Principal Market nor           shall
suspension by the SEC or the Principal Market have been threatened, as of           the
Closing Date, either (A) in writing by the SEC or the Principal Market or           (B)
by falling below the minimum listing maintenance requirements of the           Principal
Market.  

29 

    
          
          (xi)                     The
Company shall have obtained all governmental, regulatory or third party
          consents and approvals, if any, necessary for the sale of the Securities.  

    
          
          (xii)                     Within
six (6) Business Days prior to the Closing, the Company shall have           delivered or
caused to be delivered to each Buyer (A) certified copies of UCC           search
results, listing all effective financing statements which name as debtor           the
Company or any of its Subsidiaries filed in the prior five years to perfect           an
interest in any assets thereof, together with copies of such financing
          statements, none of which, except as otherwise agreed in writing by the Buyers,
          shall cover any of the Collateral (as defined in the Security Documents) and
the           results of searches for any tax lien and judgment lien filed against such
Person           or its property, which results, except as otherwise agreed to in writing
by the           Buyers shall not show any such Liens (as defined in the Security
Documents); and           (B) a perfection certificate, duly completed and executed by
the Company and           each of its Subsidiaries, in form and substance satisfactory to
the Buyers.  

    
          
          (xiii)                     Such
Buyer shall have received lock-up agreements in the form attached hereto as
          Exhibit K (the “Lock-Up Agreements”, duly executed and
          delivered by each of Rachelle Stein, Regency Capital Management, Merit
          Investments, Martin Silver and Madeline Silver as Joint Tenants, Ronald
          Sparkman, David C. Skinner, Sr and Kimberley Skinner as Joint Tenants and
          Kristine Coalson and Kim Skinner Ttee Kimberley and David C Skinner Family
Trust           and the Company, which limits the rights of such persons to sell or
transfer           Common Stock of the Company until the second anniversary of the
Closing Date.  

    
          
          (xiv)                     The
Company shall have delivered to such Buyer such other documents relating to           the
transactions contemplated by this Agreement as such Buyer or its counsel may
          reasonably request.  

    8.           TERMINATION.
In the event that the Closing shall not have occurred with           respect to a Buyer
on or before five (5) Business Days from the date hereof due           to the Company’s
or such Buyer’s failure to satisfy the conditions set           forth in Sections 6
and 7 above (and the nonbreaching party’s failure to           waive such
unsatisfied condition(s)), the nonbreaching party shall have the           option to
terminate this Agreement with respect to such breaching party at the           close of
business on such date without liability of any party to any other           party;
PROVIDED, however, that if this Agreement is terminated pursuant           to this
Section 8, the Company shall remain obligated to reimburse the           non-breaching
Buyers for the expenses described in Section 4(g) above.  

30 

    9.                     MISCELLANEOUS.  

    
          (a)           Governing
Law; Jurisdiction; Jury Trial. All questions concerning the           construction,
validity, enforcement and interpretation of this Agreement shall           be governed by
the internal laws of the State of New York, without giving effect           to any choice
of law or conflict of law provision or rule (whether of the State           of New York
or any other jurisdictions) that would cause the application of the           laws of any
jurisdictions other than the State of New York. Each party hereby           irrevocably
submits to the exclusive jurisdiction of the state and federal           courts sitting
in The City of New York, Borough of Manhattan, for the           adjudication of any
dispute hereunder or in connection herewith or with any           transaction
contemplated hereby or discussed herein, and hereby irrevocably           waives, and
agrees not to assert in any suit, action or proceeding, any claim           that it is
not personally subject to the jurisdiction of any such court, that           such suit,
action or proceeding is brought in an inconvenient forum or that the           venue of
such suit, action or proceeding is improper. Each party hereby           irrevocably
waives personal service of process and consents to process being           served in any
such suit, action or proceeding by mailing a copy thereof to such           party at the
address for such notices to it under this Agreement and agrees that           such
service shall constitute good and sufficient service of process and notice
          thereof. Nothing contained herein shall be deemed to limit in any way any right
          to serve process in any manner permitted by law. EACH PARTY HEREBY
          IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY
          TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR
          ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY. 

    
          (b)           Counterparts.
This Agreement may be executed in two or more identical           counterparts, all of
which shall be considered one and the same agreement and           shall become effective
when counterparts have been signed by each party and           delivered to the other
party; provided that a facsimile signature shall be           considered due execution
and shall be binding upon the signatory thereto with           the same force and effect
as if the signature were an original, not a facsimile           signature.  

    
          (c)           Headings.
The headings of this Agreement are for convenience of reference           and shall not
form part of, or affect the interpretation of, this Agreement.  

    
          (d)           Severability.
If any provision of this Agreement shall be invalid or           unenforceable in any
jurisdiction, such invalidity or unenforceability shall not           affect the validity
or enforceability of the remainder of this Agreement in that           jurisdiction or
the validity or enforceability of any provision of this           Agreement in any other
jurisdiction.  

    
          (e)           Entire
Agreement; Amendments. This Agreement and the other Transaction           Documents
supersede all other prior oral or written agreements between the           Buyers, the
Company, their affiliates and Persons acting on their behalf with           respect to
the matters discussed herein, and this Agreement, the other           Transaction
Documents and the instruments referenced herein and therein contain           the entire
understanding of the parties with respect to the matters covered           herein and
therein and, except as specifically set forth herein or therein,           neither the
Company nor any Buyer makes any representation, warranty, covenant           or
undertaking with respect to such matters. No provision of this Agreement may           be
amended other than by an instrument in writing signed by the Company and the
          holders of at least a majority of the aggregate number of Registrable
Securities           issued and issuable hereunder and under the Notes, and any amendment
to this           Agreement made in conformity with the provisions of this Section 9(e)
shall be           binding on all Buyers and holders of Securities, as applicable. No
provision           hereof may be waived other than by an instrument in writing signed by
the party           against whom enforcement is sought. No such amendment shall be
effective to the           extent that it applies to less than all of the holders of the
applicable           Securities then outstanding. No consideration shall be offered or
paid to any           Person to amend or consent to a waiver or modification of any
provision of any           of the Transaction Documents unless the same consideration
also is offered to           all of the parties to the Transaction Documents, holders of
Notes or holders of           the Warrants, as the case may be. The Company has not,
directly or indirectly,           made any agreements with any Buyers relating to the
terms or conditions of the           transactions contemplated by the Transaction
Documents except as set forth in           the Transaction Documents. Without limiting
the foregoing, the Company confirms           that, except as set forth in this
Agreement, no Buyer has made any commitment or           promise or has any other
obligation to provide any financing to the Company or           otherwise.  

31 

    
          (f)           Notices.
Any notices, consents, waivers or other communications required           or permitted to
be given under the terms of this Agreement must be in writing           and will be
deemed to have been delivered: (i) upon receipt, when delivered           personally;
(ii) upon receipt, when sent by facsimile (provided confirmation of
          transmission is mechanically or electronically generated and kept on file by
the           sending party); or (iii) one Business Day after deposit with an overnight
          courier service, in each case properly addressed to the party to receive the
          same. The addresses and facsimile numbers for such communications shall be:  

	 	
If
to the Company:

	 	
Amish
Naturals, Inc.
                                     8224 County Road 245

                                    Holmesville, Ohio 44633

                                    Telephone:          (330) 677-0998

                                    Facsimile:         (330) 279 2415

                                    Attention:           David Skinner, Sr., President

	 	
With
a copy to:

	 	
Dennis
Brovarone, Esq. 
                                    Attorney at Law

                                    18 Mountain Laurel Drive

                                    Littleton, Colorado 80127

                                    Telephone:          (303) 466-4092

                                    Facsimile:       (303) 466-4826

	 	
If
to the Transfer Agent:

	 	
American
Stock Transfer & Trust Company                                     
6201 15th Avenue

                                    Brooklyn NY 11204

                                    Telephone:          (718) 921-8275

                                    Facsimile:            (718) 921-8331

                                    Attention:      Paula Caroppoli Vice President

32 

If to a Buyer, to its address and
facsimile number set forth on the Schedule of Buyers, with copies to such Buyer’s
representatives as set forth on the Schedule of Buyers, <PRE> 

	 	
with
a copy (for informational purposes only) to: 

	 	
Schulte
Roth & Zabel LLP 
919 Third Avenue 
New York, New York 10022 
Telephone:
    (212) 756-2000

Facsimile:       (212) 593-5955 
Attention:
      Eleazer N. Klein, Esq. 

or to such other address and/or
facsimile number and/or to the attention of such other Person as the recipient party has
specified by written notice given to each other party five (5) days prior to the
effectiveness of such change. Written confirmation of receipt (A) given by the recipient
of such notice, consent, waiver or other communication, (B) mechanically or electronically
generated by the sender’s facsimile machine containing the time, date, recipient
facsimile number and an image of the first page of such transmission or (C) provided by an
overnight courier service shall be rebuttable evidence of personal service, receipt by
facsimile or receipt from an overnight courier service in accordance with clause (i), (ii)
or (iii) above, respectively. 

    
          (g)           Successors
and Assigns. This Agreement shall be binding upon and inure to           the benefit
of the parties and their respective successors and assigns,           including any
purchasers of the Notes or the Warrants. The Company shall not           assign this
Agreement or any rights or obligations hereunder without the prior           written
consent of the holders of at least a majority of the aggregate number of
          Registrable Securities issued and issuable hereunder, including by way of a
          Fundamental Transaction (unless the Company is in compliance with the
applicable           provisions governing Fundamental Transactions set forth in the Notes
and the           Warrants). A Buyer may assign some or all of its rights hereunder
without the           consent of the Company, in which event such assignee shall be
deemed to be a           Buyer hereunder with respect to such assigned rights.  

    
          (h)           No
Third Party Beneficiaries. This Agreement is intended for the benefit           of
the parties hereto and their respective permitted successors and assigns, and
          is not for the benefit of, nor may any provision hereof be enforced by, any
          other Person.  

    
          (i)           Survival.
Unless this Agreement is terminated under Section 8, the           representations and
warranties of the Company and the Buyers contained in           Sections 2 and 3, and the
agreements and covenants set forth in Sections 4, 5           and 9 shall survive the
Closing. Each Buyer shall be responsible only for its           own representations,
warranties, agreements and covenants hereunder.  

    
          (j)           Further
Assurances. Each party shall do and perform, or cause to be done           and
performed, all such further acts and things, and shall execute and deliver           all
such other agreements, certificates, instruments and documents, as any other
          party may reasonably request in order to carry out the intent and accomplish
the           purposes of this Agreement and the consummation of the transactions
contemplated           hereby.  

33 

    
          (k)           Indemnification.
In consideration of each Buyer’s execution and           delivery of the Transaction
Documents and acquiring the Securities thereunder           and in addition to all of the
Company’s other obligations under the           Transaction Documents, the Company
shall defend, protect, indemnify and hold           harmless each Buyer and each other
holder of the Securities and all of their           stockholders, partners, members,
officers, directors, employees and direct or           indirect investors and any of the
foregoing Persons’ agents or other           representatives (including, without
limitation, those retained in connection           with the transactions contemplated by
this Agreement) (collectively, the           “Indemnitees”) from and
against any and all actions, causes of           action, suits, claims, losses, costs,
penalties, fees, liabilities and damages,           and expenses in connection therewith
(irrespective of whether any such           Indemnitee is a party to the action for which
indemnification hereunder is           sought), and including reasonable attorneys’ fees
and disbursements (the           “Indemnified Liabilities”), incurred by
any Indemnitee as a           result of, or arising out of, or relating to (a) any
misrepresentation or breach           of any representation or warranty made by the
Company in the Transaction           Documents or any other certificate, instrument or
document contemplated hereby           or thereby, (b) any breach of any covenant,
agreement or obligation of the           Company contained in the Transaction Documents
or any other certificate,           instrument or document contemplated hereby or thereby
or (c) any cause of           action, suit or claim brought or made against such
Indemnitee by a third party           (including for these purposes a derivative action
brought on behalf of the           Company) and arising out of or resulting from (i) the
execution, delivery,           performance or enforcement of the Transaction Documents or
any other           certificate, instrument or document contemplated hereby or thereby,
(ii) any           transaction financed or to be financed in whole or in part, directly
or           indirectly, with the proceeds of the issuance of the Securities, (iii) any
          disclosure made by such Buyer pursuant to Section 4(i), or (iv) the status of
          such Buyer or holder of the Securities as an investor in the Company pursuant
to           the transactions contemplated by the Transaction Documents. To the extent
that           the foregoing undertaking by the Company may be unenforceable for any
reason,           the Company shall make the maximum contribution to the payment and
satisfaction           of each of the Indemnified Liabilities that is permissible under
applicable law.           Except as otherwise set forth herein, the mechanics and
procedures with respect           to the rights and obligations under this Section 9(k)
shall be the same as those           set forth in Section 6 of the Registration Rights
Agreement.  

    
          (l)           No
Strict Construction. The language used in this Agreement will be           deemed to
be the language chosen by the parties to express their mutual intent,           and no
rules of strict construction will be applied against any party.  

    
          (m)           Remedies.
Each Buyer and each holder of the Securities shall have all           rights and remedies
set forth in the Transaction Documents and all rights and           remedies which such
holders have been granted at any time under any other           agreement or contract and
all of the rights which such holders have under any           law. Any Person having any
rights under any provision of this Agreement shall be           entitled to enforce such
rights specifically (without posting a bond or other           security), to recover
damages by reason of any breach of any provision of this           Agreement and to
exercise all other rights granted by law. Furthermore, the           Company recognizes
that in the event that it fails to perform, observe, or           discharge any or all of
its obligations under the Transaction Documents, any           remedy at law may prove to
be inadequate relief to the Buyers. The Company           therefore agrees that the
Buyers shall be entitled to seek temporary and           permanent injunctive relief in
any such case without the necessity of proving           actual damages and without
posting a bond or other security.  

34 

    
          (n)           Rescission
and Withdrawal Right. Notwithstanding anything to the contrary           contained in
(and without limiting any similar provisions of) the Transaction           Documents,
whenever any Buyer exercises a right, election, demand or option           under a
Transaction Document and the Company does not timely perform its related
          obligations within the periods therein provided, then such Buyer may rescind or
          withdraw, in its sole discretion from time to time upon written notice to the
          Company, any relevant notice, demand or election in whole or in part without
          prejudice to its future actions and rights.  

    
          (o)           Payment
Set Aside. To the extent that the Company makes a payment or           payments to
the Buyers hereunder or pursuant to any of the other Transaction           Documents or
the Buyers enforce or exercise their rights hereunder or           thereunder, and such
payment or payments or the proceeds of such enforcement or           exercise or any part
thereof are subsequently invalidated, declared to be           fraudulent or
preferential, set aside, recovered from, disgorged by or are           required to be
refunded, repaid or otherwise restored to the Company, a trustee,           receiver or
any other Person under any law (including, without limitation, any           bankruptcy
law, foreign, state or federal law, common law or equitable cause of           action),
then to the extent of any such restoration the obligation or part           thereof
originally intended to be satisfied shall be revived and continued in           full
force and effect as if such payment had not been made or such enforcement           or
setoff had not occurred.  

    
          (p)           Independent
Nature of Buyers’ Obligations and Rights. The           obligations of each
Buyer under any Transaction Document are several and not           joint with the
obligations of any other Buyer, and no Buyer shall be responsible           in any way
for the performance of the obligations of any other Buyer under any           Transaction
Document. Nothing contained herein or in any other Transaction           Document, and no
action taken by any Buyer pursuant hereto or thereto, shall be           deemed to
constitute the Buyers as, and the Company acknowledges that the Buyers           do not
so constitute, a partnership, an association, a joint venture or any           other kind
of entity, or create a presumption that the Buyers are in any way           acting in
concert or as a group, and the Company will not assert any such claim           with
respect to such obligations or the transactions contemplated by the           Transaction
Documents and the Company acknowledges that the Buyers are not           acting in
concert or as a group with respect to such obligations or the           transactions
contemplated by the Transaction Documents. The Company acknowledges           and each
Buyer confirms that it has independently participated in the           negotiation of the
transaction contemplated hereby with the advice of its own           counsel and
advisors. Each Buyer shall be entitled to independently protect and           enforce its
rights, including, without limitation, the rights arising out of           this Agreement
or out of any other Transaction Documents, and it shall not be           necessary for
any other Buyer to be joined as an additional party in any           proceeding for such
purpose.  

[Signature Page
Follows] 

35 

        IN
WITNESS WHEREOF, each Buyer and the Company have caused their respective signature
page to this Securities Purchase Agreement to be duly executed as of the date first
written above. 

		
		COMPANY:

AMISH NATURALS, INC.

By: /s/ David Skinner, Sr.

       Name: David Skinner, Sr.

       Title: President 

36 

        IN
WITNESS WHEREOF, each Buyer and the Company have caused their respective signature
page to this Securities Purchase Agreement to be duly executed as of the date first
written above. 

		
		BUYER:

CASTLERIGG MASTER INVESTMENTS LTD.

By: /s/ Timothy O'Brien

       Name:  Timothy O'Brien

       Title:  Chief Financial Officer 

SCHEDULE OF BUYERS 

        	
                    
                    (1)

                	
                    
                    (2)

                	
                    
                    (3)

                	
                    
                    (4)

                	
                    
                    (5)

                	
                    
                    (6)

                	
                    
                    (7)`

                	
                    
                    (8)

                	
                    
                    (9)

                
	
                    
                    Buyer

                	
                    
                    Address and

                    Facsimile Number

                	
                    
                    Aggregate

                    Principal

                    Amount of

                    Notes

                	
                    
                    Number of

                     Series E

                    Warrant Shares

                	
                    
                    Number of

                     Series F

                    Warrant Shares

                	
                    
                    Prepaid Interest

                	
                    
                    Purchase Price

                	
                    
                    Net Purchase Price

                	
                    
                    Legal Representative's Address and Facsimile
                    Number

                
	 	 	 	 	 	 	 	 	 
	
                    
                    Castlerigg Master Investments
                    Ltd.

                	
                    
                    c/o Sandell Asset Management

                    40 West 57th St

                    26th Floor

                    New York, NY 10019

                    Attention: Cem Hacioglu/Matthew Pliskin

                    Fax: 212-603-5710

                    Telephone: 212-603-5700

                    Residence: British Virgin Islands

                	
                    
                    $3,125,000

                	
                    
                    5,000,000

                	
                    
                    2,500,000

                	
                    
                    $625,000

                	
                    
                    $3,125,000

                	
                    
                    $2,500,000

                	
                    
                    Schulte Roth & Zabel LLP

                    919 Third Avenue

                    New York, New York 10022

                    Attention: Eleazer Klein, Esq.

                    Facsimile: (212) 593-5955

                    Telephone: (212) 756-2376

                
	 	 	 	 	 	 	 	 	 

        

        

EXHIBITS  

		
	Exhibit A 

Exhibit B 

Exhibit C 

Exhibit D 

Exhibit E 

Exhibit F 

Exhibit G 

Exhibit H 

Exhibit I 

Exhibit J 

Exhibit K
	Form of Notes

Form of Warrants

Form of Registration Rights Agreement

Form of Pledge Agreement

Form of Security Agreement

Form of Guaranty

Form of Irrevocable Transfer Agent Instructions

Form of Opinion of Company's Counsel

Form of Secretary's Certificate

Form of Officer's Certificate

Form of Lock-Up Agreement

SCHEDULES  

		
	Schedule 3(a) 

Schedule 3(k) 

Schedule 3(l) 

Schedule 3(q) 

Schedule 3(r) 

Schedule 3(s) 

Schedule 3(t) 

Schedule 3(x) 

Schedule 3(z) 

Schedule 3(ee)
	Subsidiaries

SEC Documents

Absence of Certain Changes

Transactions with Affiliates

Equity Capitalization

Indebtedness and Other Contracts

Absence of Litigation

Intellectual Property Rights

Subsidiary Rights

Ranking of Notes

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}]]